Program  by unknown
Sunday, March I.8 Monday, March 19 Tuesday, March 20 Wednesday, March 21 
Exhibits open noon-5 p.m. Ekhibits open 9 am-5 p.m. Fxhibits open 9 am-5 p.m. Exhibits open 9 a.m.~noon 
Abstract Presentations 
The American College of Cardiology is pleased to announce that nearly 7,300 abstracts of original contributions were 
submitted to the Program Committee of the 50th Annual Scientific Session. Space and time considerations this year allowed the 
selection of more than 2,300. Each paper was peer reviewed by a panel of graders; chosen abstracts are presented in either oral 
or poster format. The American College of Cardiology thanks the thousands of abstract participants and the hundreds of 
category graders and chairs for their efforts. 
John P. DiMarco, MD, PhD, FACC 
Chair, 2001 Annual Scientific Session Program Committee 
Sanjiv Kaul, MBBS, FACC 
Co-Chair, 200 1 Annual Scientific Session Program Committee 
Country 
UN ITED STATES 1,239 52.86 
AFGHANISTAN 1 .04 
ARGENTINA 3 .I 3 
AUSTRALIA 28 1.19 
AUSTRIA 9 .38 
BELGIUM 20 .85 
BRAZIL 23 .98 
CANADA 61 2.60 
CHILE 1 .04 
CZECH REPUBLIC 2 .09 
DENMARK 13 .55 
EGYPT 1 .04 
FINLAND 6 .26 
FRANCE 57 2.43 
GERMANY 179 7.64 
GREECE 39 1.66 
HONG KONG 8 .34 
INDIA 4 .I 7 
ISRAEL 19 .81 
ITALY 122 5.20 
JAPAN 187 7.98 
Presentations 
ACC 2001 TOTAL PRESENTATIONS: 2,344 
% 
of Total 
% 
Country Presentations of Total 
MEXICO 1 .04 
NEW ZEALAND 5 .21 
NORWAY 5 .21 
PEOPLE’S REPUBLIC OF CHINA 7 .30 
PHILIPPINES 
POLAND 
PORTUGAL 
SAUDI ARABIA 
SINGAPORE 
SOUTH AFRICA 
SOUTH KOREA 
SPAIN 
SWEDEN 
SWITZERLAND 
TAIWAN, ROC 
THAILAND 
THE NETHERLANDS 
TUNISIA 
TURKEY 
UNITED KINGDOM 
YUGOSLAVIA 
U.S.: 52.86% 
1 .04 
3 .I3 
2 .09 
3 .I3 
.3 .I3 
2 .09 
17 .73 
15 .64 
19 .81 
24 1.02 
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5 .21 
INTERNATIONAL: 47.14% 
The receipt deadline for submission of abstracts to be considered for presentation at the 
American College of Cardiology 51 st Annual Scientific Session, March 17-20, 2002, 
in Atlanta, Georgia, is Friday, September 7, 2001. 

Scientific Sessions 
Session Key 
Each education session has been assigned an icon and a 
number which correspond to the format in which the session 
is presented. 
20-80 Series= Spotlight Sessions 
Sunday, March 18 m 
Five comprehensive programs in focused areas of cardiology 
are offered on Sunday: ACCIS 2001 (Interventional), 
ClinCard 2001 (Clinical Cardiology), Echo 2001 
(Echocardiography), EP 2001 (Electrophysiology), and 
Nuclear 2001 (N UC 1 ear Cardiology). The full-day programs 
feature live case demonstrations, expert faculty, and inter- 
active case presentations. 
There is no charge to attend these sessions. Admission 
is by badge only on a first-come, first-served basis. 
m 100 Series= Mini-Courses Sunday, March 18 pg 
The purpose of these sessions is to provide an in-depth 
update, including research data, on topics of major clinical 
interest. The half-day courses generally appeal to practicing 
and academic clinical cardiovascular specialists. 
There is no charge to attend these sessions. Admission 
is by badge only on a first-come, first-served basis. 
mm y;E 200 Series=Meet the Experts Monday, March I9-Wednesday, March 2 1 a 
The purpose of these sessions is to provide a scholarly 
exchange of information in an informal setting between two 
recognized authorities and a small group of cardiologists. 
Objectives are that the particijrant will: 
1. Review the differential diagnosis, diagnostic logic and 
techniques, and current knowledge of disease and 
pathophysiology, where appropriate, in discussions. 
2. Identify and discuss his/her interests and needs. 
3. Participate actively. 
Attendees are encouraged to bring questions, and cases or 
scenarios for discussion. 
@ 
Attendance is limited to 80. There is no charge to 
attend these sessions; however, registrants must 
enroll due to limited seating. Admission is by ticket 
only; limit 2 sessions per person. Arrive firornfitb for the 
session; in case of a sell-out, stand-by tichets will be issued and 
your seat may be “S-e-sold”. 
300 Series = Brown Bag 
Lunchtime Panels 
Monday, March 19-Wednesday, March 2 1 m 
The purpose of these sessions is to address current practice 
issues in cardiovascular medicine. A chair and three to four 
panelists preside over an interactive discussion. Each 
panelist presents five- to seven-minute introductory remarks. 
The remaining 30-40 minutes of the session are devoted to 
questions from the audience. Where applicable, a case 
presentation will be distributed to the audience for 
discussion at the end of the session. As audiovisual aids are 
not permitted, audience members are encouraged to bring 
questions and cases and participate in the discussion to fully 
benefit from the informal interchange. 
Objectives are that the participant will: 
1. Distinguish the major issues, techniques, and management 
options in cardiovascular practice. 
2. Discuss and ask questions about topics of interest. 
69 
There is no charge to attend these sessions. 
Attendees may purchase food service items, at their 
own exfiense, from any of the convention center conces- 
sions and bring their “brown bag” lunch into the session 
room. ACC will not provide lunch. Admission is by badge only 
on a first-come, first-served basis. 
m mm 400 Series=Special Sessions Sunday, March 18-Wednesday, March 21 m 
Among those highlighted are the Presidential Plenary 
Session, Late Breaking Clinical Trial sessions, Young 
Investigators Awards Competition, Controversies in 
Cardiology, Annual Louis F. Bishop Lecture, the Annual 
Convocation Ceremony, and the popular Highlights 
Session on Wednesday. 
There is no charge to attend these sessions. Admission is by 
badge only on a first-come, first-served basis. 
cientific Sessions 
V 
500 Series= Evening Sessions 
Sunday, March 18 and Tuesday, March 20 m 
The purpose of these sessions is to address and discuss 
information presented by the panelists who are involved 
clinically or in research related to the topic. Audience 
participation is an integral part of these informal sessions. 
Each panelist will give a five- to seven-minute introduction 
with the remainder of the session devoted to questions and 
discussion. 
Objectives are that the $artici$ant will: 
1. Update his/her knowledge in the techniques, advance- 
ments, and new developments concerning the topic. 
2. Propose questions, areas or topics of interest, and 
“problem” cases or scenarios for discussion according to 
his/her needs. 
?here is no charge to attend these sessions. Admission is by 
badge only on a first-come, first-served basis. 
600 Series=Symposia 
Monday, March 19-Wednesday, March 21 m 
The purpose of these sessions is to present detailed 
discussions of cardiovascular topics by individuals who have 
directly contributed information to the subject. Symposia 
include sessions of both general clinical interest as well as 
sessions with focused interest for subspecialists in various 
aspects of scientific, clinical, and procedural cardiology. 
There is no charge to attend these sessions. Admission is by 
badge only on a first-come, first-served basis. 
mm 
mm 
700 Series = Core Curricula 
Monday, March 19-Wednesday, March 2 I m 
The purpose of these sessions is to provide practicing clini- 
cians with comprehensive up-to-date information about 
developments in pathophysiology and therapy which are 
relevant to the care of patients, now and in the future. 
Objectives are that the $artici$ant will: 
1. Review and evaluate new directions and practices in 
cardiology. 
2. Integrate new concepts in basic mechanisms of disease 
into a clinical perspective. 
3. Examine results of recent clinical trials as they pertain to 
their immediate and mture impact on clinical practice. 
There is no charge to attend these sessions. Admission is by 
badge only on a first-come, first-served basis. 
600 Series = 
Original Contributions-Oral 
Monday, March 1 g-Wednesday, March 2 1 
There is no charge to attend these sessions. 
1000-1300 Series= 
mm 
Original Contributions-Poster 
Sunday, March 18-Wednesday, March 2 1 
There is no charge to attend these sessions. 
m I.500 Series=info@ACC Theater, 
mm 
Classroom, and Computer Abstract 
Presentations 
Sunday, March 1 S-Wednesday, March 2 1 
The info@ACC Theater includes presentations on infor- 
mation technology. Computer abstract presentations are for 
original peer-reviewed software applications. 
The info@ACC Classroom sessions provide hands-on 
computer training on the :use of the Internet and other new 
computer-based resources to describe how they may be 
effectively used by the cardiovascular professional. 
@ 
Attendance is limited to 28. There is no charge to 
attend these sessions; however, registrants must 
enroll due to limited seating. Admission is by t&et 
only; limit 2 sessions per $erson. Arrive promfit& for the 
session; in case of a sell-out, stand-by tickets will be issued and 
your seat may be “‘re-sold”. 
Gunday, March 18 
B 230 a.m.-&45 a.m. 
M State-of-the-Art 
.ectures: Treatment of lschemic 
:oronary Artery Disease, Ha//E 
B 5~45 a.m.-1090 a.m. 
w Late Breaking Clinical 
rials in Interventional 
Iardiology, Hall E 
B M:OO a.m.-Noon 
W Live Interventional 
Iase Demonstrations I, Ha// E 
B lo:00 a.m.-Noon 
W Physiologic and 
inatomic Assessment: Case 
leviews, Hull f7 
B lo:00 a.m.-Noon 
M Arterial Access Issues, 
‘la/l FS 
B Noon-200 p.m. 
w Coronary Stents: Druq 
Ielivery, Ha//A4 ’ 
B Noon-ZOO p.m. 
m New Methods for 
Ietecting Vulnerable Plaque I, 
Yall A4 
B Noon-200 p.m. 
m Complications 
bsociated With Percutaneous 
Coronary Interventions, Hall A4 
B Noon-200 p.m. 
m Straight to the Heart: 
Methods and Outcomes of 
Delivery, Hall A4 
B 1:30 p.mX%OO p.m. 
w Live and Taped 
nterventional Case ’ 
3emonstrations II, Hall E 
B k30 p.m.-3S p.m. 
II Complications: 
Jrevention, Recognition, and 
tianagement, Hall F7 
B k30 p.m.GM5 p.m. 
m Problem Solving in 
nterventional Cardiology, 
Hall F-5 
B k30 p.mAl5 p.m. 
If Interventional 
Cardiology Highlighted Abstract 
Session.. .Coronary Stents: 
Featured Investigation, Hall F3 
B 300 p.m.5:00 p.m. 
m lnterventional Cardio- 
logy Highlighted Abstract Session 
. ..Coronarv Stents: Technical 
Considera6ons, Hall A4 
B 3:OO p.m.b:OO p.m. 
cT;F) Use of Fractional Flow 
Reserve in Clinical Practice, 
Hall A4 
m*rrJ 3:OO p.m.5:OO p.m. 
m Local Therapies for 
Restenosis Control: Clinical 
Studies, Hall A4 
B 3:OO p.mA%OO p.m. 
m Outcomes Analysis I, 
Hall A4 
w 3:30 p.m.430 p.m. 
m Great Debates in 
Peripheral Vascular Disease, 
Ha// F7 
B 3:30 p.m.-5i30 p.m. 
m Matchina Lesions and 
d Devices, Hall F5 
B 400 p.m.*30 p.m. 
U Interventional Cardio- 
logy Highlighted Abstract Session 
. ..Predictors of Restenosis, Hall F3 
w 5:30 p.m.-200 p.m. 
m Radiation Devices, 
Hall F3 
w 5~30 p.m.-200 p.m. 
m In-Stent Restenosis, 
Hall F7 
B 5:30 p.m.-200 p.m. 
m Alternative Revascu- 
larization Strategies, Hall F4 
B 5~30 p.m.-R00 p.m. 
m New Directions in 
Catheter-Based Imaging, Hall F5 
donday, March 19 
B 8:OO a.m.400 a.m. 
B Presidential Plenary 
,ession, Hall E 
B 5~00 a.m.-10:OO a.m. 
B Functional Assessment 
)f the Intermediate Coronary 
.esions, Room 224A SE 
B 5~00 a.m.-10:OO a.m. 
B Stent Selection, 
loom 2248 aa 
B 900 a.m.-11:OO a.m. 
B New Methods for 
Ietecting Vulnerable Plaque II, 
-la// A4 
B StOOa.m.-lliO0 a.m. 
B Coronary Stents: 
idjunctive Techniqbes, Hal/A4 
B 9:OO a.m.-ii:00 a.m. 
B Outcomes Analysis II, 
Yall A4 
B 990 a.m.-11:OO a.m. 
B Clinical Studies of 
Diverse Vascular Therapies, 
Va// A4 
w 9:15 a.m.-%30 a.m. 
w Business Meeting of 
ihe College, Room 2308 
B Oil5 a.m.-109 a.m. 
B ACCIAHA 
Percutaneous Transluminal 
Coronary Angioplasty Guidelines: 
2001, Hall F7 
B 9:15 a.m.-U):30 a.m. 
m lntracoronary 
Radiation: Part I, Hall /% 
B 9:15a.m.-l&30 a.m. 
B Restenosis: Novel 
Therapies, Hall f3 
w 9:15a.m.-109 a.m. 
w Intravascular 
Ultrasound Guided Percutaneous 
Coronary Intervention I, Hall F4 
m lOt30a.m.~lk30a.m. 
pm Rotational 
Atherectomy, Room 224A m 
m lo:30 a.m.-ii:30 a.m. 
m Preventive Treatment 
After Intervention, , 
Room 224 B WE 
m ii:00 a.m.-CM5 p.m. 
m Current Status of 
Mitral Valvuloplasty, Hall F7 
w 11:OOa.m~iZ:15 p.m. 
m lntracoronary 
Radiation: Part II, Hall FS 
B 1lzOOa.m~139.5 p.m. 
B Interventional Case 
‘resentations, Hall E 
bm lM0 a.mr1215 p.m. 
B Inflammation and 
indothelial Activation: Effects 
)n Percutaneous Coronary 
ntervention Outcomes, Hall F3 
B 11:00a.mr12:15 p.m. 
B Brachytherapy: 
3ngoing Issues, Ha// F+ 
B Noon-NO p.m. 
B Renal Interventions, 
Vu// A4 
B Noon400 p.m. 
B Coronary Stents: 
4djunctive Treatment, Hall A4 
m Noon-200 p.m. 
M New Techniques: 
Strategies for Intervention I, 
Hall A4 
m Noon-200 p.m. 
B Restenosis: Vascular 
Remodeling and Apoptosis, 
Hall A4 
B CM5 p.m.-It45 p.m. 
bm Carotid Intervention: 
Which Patients Should Be Treated 
and by Whom?, Room 709A 
B 12:l5 p.m.-M5 p.m. 
pr] CP Ilb-llla Inhibitors: 
When Should They Be Used?, 
Room 7 7OA 
w 2~00 p.m.-3:30 p.m. 
m New Coronary 
- Devices, Hall F7 
m 200 p.m.-3:30 p.m. 
B Decision Making 
During Percutaneous Coronary 
Intervention, Hall E 
Eq 290 p.m.-3:30 p.m. 
m Coronary Stents: 
Predictors of Outcome, Hall F5 
m 7.~00 p.m.3:30 p.m. 
w Carotid Interventions I, 
Ha// F4 
w 230 p.m.Gk30 p.m. 
w Carotid Percutaneous 
Transluminal Coronary Angio- 
plasty and Stenting: Indications 
and Techniqudase Reviews, 
Room 224A m 
(Continued next page, 
vii 
Monday, March 19 
B 2:30 p.m.3:30 p.m. 
B Bifurcation Lesions, 
Room 2246 a 
m 300 p.m.-%00 p.m. 
m Coronary Stents: 
;lir$c;l Predictors of Outcome, 
Ultrasound Insights Into 
Atherosclerosis and Restenosis I, 
Hail A4 
B 3:OO p.m.-&00 p.m. 
B Local Deliverv 
Approaches for Angiogenesis and 
Restenosis, Ha// A4 
w 300 p.m.-%00 p.m. 
m New Techniques: 
Strategies for intervention II, 
Hall A4 
m 400 p.m.-!%00 p.m. 
m Interventions: Adult 
Congenital Heart Disease, 
Room 224A recar 
m 4:00 p.m.-&00 p.m. 
m Management of Lipids 
Following Intervention, 
Room 2245 #a# 
B 4:00 p.m.-&30 p.m. 
m Peripheral Artery 
Disease, Ha77 F.5 
Interventional Cardiology, 
Hall E 
m 4~00 p.m.-%30 p.m. 
v Renal Artery Stenosis: 
Diagnosis and Management, 
Hall F7 
m 4:OO p.m.430 p.m. 
sm Coronary Stents: 
Biodegradable and Local Drug 
Delivery, Hall F4 
Tuesday, March 20 
m 8:30a.m.-10~00 a.m. 
w Controversial Issues in 
Coronary Stenting, Hall F.5 
Syndromes, Ha// F7 
m 8:30 a.m.-10:OO a.m. 
m Therapeutic 
Angiogenesis Biological and 
Mechanical Approaches, Hall F4 
m 9:OOa.m.~1O:OOa.m. 
B Approaching the 
Lesions With Thrombus, 
Room 224A m 
m 9:OO a.m.-ii:00 a.m. 
m Restenosis: Cellular 
Response to Injury, Hall A4 
m 900 a.m.-l&00 a.m. 
m Carotid Interventions II, 
Hall A4 
m 9:OOa.m~1lzOOa.m. 
IEr:r Coronary Stents: 
Special Applications, Hall A4 
ggg 
9~00 a.m.-li:OO a.m. 
Brachytherapy, 
Hall A4 
B lo:30 a.m.-l&30 a.m. 
w Alcohol Ablation for 
Hypertrophic Obstructive Car- 
diomyopathy, Room 224A m 
w lOz30a.m.~llt30 a.m. 
m Renal Artery Stenting: 
Techniques, Complications, 
Avoidance, and Case Reviews, 
Room 2248 nn 
m lo:30 a.m.-Noon 
m Intervention in 
Challenging Patient Subsets, 
Hall E 
m lo:30 a.m.-Noon 
m New Adjunctive 
Therapy, Hall F7 
m lo:30 a.m.-Noon 
w Strategies for 
Intervention, Hall F5 
m lo:30 a.m.-Noon 
m Radiation Therapy for 
Restenosis: Insights From 
Intravascular Ultrasound, Ha// F4 
i 1 
B Noon-200 p.m. 
B Moderated Poster 
Session...Coronary Physiology: 
Strategies for Intervention- 
Lliscellaneous, Hall A4 
v Noon400 p.m. 
v Coronary Stems: 
Radiation, Ha// A4 
B Noon-200 p.m. 
B Intravascular Ultrasound 
Insights Into Atherosclerosis and 
Restenosis II, Ha// A4 
iI 1 
Coronary Intervention in 
Diabetes, Hall A4 
m Noon-200 p.m. 
B Transmvocardial Laser 
Revascularization: Positive, 
Negative, or Neutral?, Hall A4 
m til5 p.m.-US p.m. 
u] Inoperable Coronary 
Artery Disease, Room 709A 
B I215 p.m.-US p.m. 
B Low Molecular Weight 
Heparin, Room 7 1 OA 
bm 200 p.mAOO p.m. 
B 32nd Annual Louis F. 
Bishop Lecture, Room 330 
v 200 p.mrj:tO p.m. 
m Lessons From 
Angioplasty Versus Surgery in 
Multivessel Disease: Have Our 
Conclusions Changed With 
Extended Long-Term Follow-Up?, 
Ha// E 
m 200 p.m.-3r30 p.m. 
B Coronary Stems: Late 
Outcome, Hall F7 
m 230 p.m.*30 p.m. 
m Treatment of 
Saphenous Vein Graft Disease, 
Room 224A mu 
m 230 p.m.-&30 p.m. 
v My Worst Nightmares 
as an Interventionalist, 
Room 2248 m 
m 3:OO p.m.-%00 p.m. 
m Restenosis: From 
Bedside to Bench, Hall A4 
(Continued next page) 
m Structured Sessions 
B (Black Boxes) 
B Abstract Sessions 
B (Crey Boxes) 
B Session lype and 
m Number are shown 
B in the shaded box. 
I(iE Refer to the Scientiic 
Sessions Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The session Tile and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March IS 
Noon-5 p.m. 
Monday, March 19 
9 a.m.-5 p.m. 
Tuesday, March 20 
9 a.m.4 p.m. 
Wednesday, March 21 
9 a.m.-Noon 
. . . 
VIII 
Tuesday, March 20 
m 300 p.m.-%00 p.m. 
B Percutaneous 
Coronary Intervention in Acute 
Vlyocardial Infarction: Pharma- 
cologic Interventions, /-full A4 
a:00 p.m.b:OO p.m. 
Coronary Stents: Local 
Factors in Outcome, Ho//A4 
m 300 p.m.-5:00 p.m. 
B Peripheral and Aortic 
L\neurysms Interventions, Ho//A4 
Room 224A 
m 400 p.m.*00 p.m. 
B Excimer Laser Angio- 
plasty in 2001, Room 224B m 
m lkO0 p.m.*00 p.m. 
B Carotid Intervention, 
Hall E 
Rkvascularization/Angiogenesis, 
Hall FT 
m 600 p.m&OO p.m. 
B Outcome Markers 
During Percutaneous Coronary 
Interventions, Hall F5 
m 5~30 p.m.+00 p.m. 
B Treatment of In- 
Laboratory Complications After 
Percutaneous Transluminal 
Coronary Angioplasty, 
Hall Fl 
m 530 p.m.-7:OO p.m. 
u! Point-of-Care Platelet 
Aggregation Monitoring, 
Hall F-5 
Convocation, Peabody Orlando, 
International Plaza Ballroom 
Wednesday, March 21 
m 8:30a.m~10:OOa.m. 
m Restenosis: Prevention 
and Treatment, Hall F5 
m &30 a.m.-10:OOa.m. .* 
w Multicenter Registries: 
What I’ve Learned From Our 
Registry That Has Changed Our 
Clinical Practice, Hall FI 
m 9:OO a.m.-l&00 a.m. 
m Chronic Total 
Occlusions, Room 224A ZPFBI 
m 3:OOa.m.~1l:OO a.m. 
m Inhibition of Platelets 
and Thrombosis in Percutaneous 
Coronary Intervention: Progress 
in Agents and Indications, 
Hall A4 
m $00 a.m.-WOO a.m. 
B Intravascular 
Ultrasound Guided Percutaneous 
Coronary Intervention II, 
Hd A4 
m 990 a.m.-l&O0 a.m. 
V Coronary Stents: 
Clinical Factors in Outcome, 
Hall A4 
m 10:30a.m.-lli30a.m. 
Iz1; Intervention in 
Multivessel Disease, 
Room 224A nlE 
m 10:30a.mAl~30a.m. 
B Acute Myocardial 
Infarction, Room 2248 aa 
m lOi a.m.-=30 p.m. 
B ACC 2001 Meeting 
Highlights, Hall E 
m lo:30 a.mrNoon 
B Adjunctive Pharma- 
cology During Percutaneous 
Coronary Intervention, Hall F1 
m 10~30 a.m.-Noon 
B Coronary Stents: 
Novel Approaches to Reduce 
Restenosis, Ha// F3 
m 12d.5 p.m.-l:45 p.m. 
w Cutting Edge: New 
Directions for Atherectomy, 
Room 7 09A 
m X&l5 p.m.-L45 p.m. 
w Acute Myocardial 
Infarction Angioplasty: When, 
Where, Whom?, Room 7 IOA 
w Structured Sessions 
B (Black Boxes) 
Abstract Sessions 
B (Crey Boxes) 
B Session Type and 
m Number are shown 
B in the shaded box. 
m Refer to the Scientific 
Sessions Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The Session Title and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March ¶.S 
Noon-S p.m. 
Monday, March 19 
9 a.m.-5 p.m. 
hesday, March 20 
9 a.m.-5 p.m. 
Wednesday, March 21 
9 a.m.-Noon 
ix 
§unday, March 18 
9~00 a.m.-l&00 a.m. 
Arrhythmia/Device 
Trial Update, f&/l A3 
b- l&O0 a.m.-Noon 
m Pacing/lmplantable 
Cardioverter Defibrillators in 
Heart Failure, Ha// A3 
Noon-200 p.m. 
Molecular and Genetic 
Bases of Ventricular Arrhythmias, 
Ha// A4 
Noon400 p.m. 
Ablation Therabv: 
Studies in Experimental Animals, 
Hall A4 
Noon-200 p.m. 
Implantable 
er Defibrillators II, 
Noon-P:OQ p.m. 
Autonomic Nervous 
System, /-/a// A4 
w k30 p.m..=&00 p.m. 
m New Mappinq 
Techniques/System&‘When Are 
They Needed?, Ha// A3 
w 200 p.m.-5:00 p.m. 
m Analysis of Complex 
Arrhythmias, Room 304 
v 300 p.m.-.%00 p.m. 
m Hybrid Therapy for 
Atrial Fibrillation in 2001, 
Ha// A3 
300 p.m.-5:OO p.m. 
Mechanisms of 
Arrhythmias, 
Ha// A4 
3:OO p.mAOO p.m. 
Pharmacological 
Therapy of Atrial Fibrillation, 
Hail A4 
300 p.m.490 p.m. 
Atrial Fibrillation: 
Clinical Issues, Ha// A4 
3:00 p.m.400 p.m. 
Pacinq/Atrial 
Fibrillation, Ha//A14 
B 510 p.m.-7:OO p.m. 
m Evaluation and 
Management of Neurocardiogenic 
Syncope, Valencia 5 
m 5~30 p.m.-k00 p.m. 
m Pacing: Update on 
Indications and Follow-Up, 
Room 4 14A 
Monday, March 19 
m 8:OO a.m.-4:OO a.m. 
m Presidential Plenary 
Session, Ha// E 
m 9~00 a.m.-10:OO a.m. 
m Patina in Conaestive 
Heart Failure, Room 224F- m 
9:OO a.m.-ii:00 a.m. 
Implantable Devices 
atment of Atrial 
Fibrillation, Ha// A4 
St00 a.m.-1l:OO a.m. 
Atrial Fibrillation: 
on and Elimination off 
Triggers, Hall A4 
9:OOa.m~1i:OOa.m. 
Electrophysiological 
of the Heart, Ha//A4 
9~00 a.m.-1i:OO a.m. 
Idiopathic Ventricular 
m 9% a.m.-*30 a.m. 
m Business Meeting of 
the College, Room 230B 
pm 99.5 a.m.-l&30 a.m. 
m Catheter Ablation in 
2001, Auditorium 
9:15 a.m.-W30 a.m. 
Atrial Defibrillators, 
Room 232A 
m lo:30 a.m.-lk30 a.m. 
YfL Evaluation and 
Management of Syncope, 
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Outcomes: Mechanisms and 
Autonomic Modulation, Ha// A4 
m Noon-1:OO ).m. 
m Risk Factors and 
Endothelial Function, /-/a// A4 
Dysfunction Ill, Ha//,44 
m NoonikW p.m. 
m Aortic and Carotid 
Disease, Ha// A4 
m 1235 p.m.-&45 p.m. 
m The Benefits of 
Aggressive Lipid-Lowering 
Therapy in Coronary Artery 
Disease, Room 1096 
m 1215 p.m.-i:45 p.m. 
Ur; Controversies in 
Renovascular Disease, Room 104 
m 200 p.m.*00 p.m. 
m 32nd Annual Louis F. 
Bishop Lecture, Room 330 
m 2:W p.m.-Z30 p.m. 
w Infection and 
Atherosclerosis, Ha// A3 
m 2:OO p.m.430 p.m. 
m Vascular Biology and 
Angiogenesis: Clinical Studies, 
Room 304A 
m 200 p.mA30 p.m. 
m Trials and 
Hypertension, Room 304E 
m 2:30 p.m.430 p.m. 
m Managing the Elderly 
Hypertensive Patient, 
Room 2.24 D zm 
3:OO p.m.-%00 p.m. 
Biology of 
Atherosclerosis, Ha// A4 
300 p.m.-%00 p.m. 
Gene Transfer, 
Inflammation, and Neointima 
Formation, Ha// A4 
3~00 p.m.5:00 p.m. 
Hypertension: 
Determinants of Cardiovascular 
Mass, Hall A4 
3~00 p.mAOO p.m. 
Rosuvastatin, Ha// A4 
3:OO p.m.5:W p.m. 
Natriuretic Peptides as 
Hemodynamic Status 
3:OO p.m.-5:W p.m. 
4:OO p.m.*00 p.m. 
Signaling Pathways of 
Hypertrophy, Room 304A 
5:30 p.m.-E00 p.m. 
Safe Alternatives to 
Angioplasty, Room 304A 
E!m 
930 p.m.+00 p.m. 
Cardiovascular Care of 
the Elderly, Room 304E 
6:OO p.m.-&W p.m. 
50th Annual 
Convocation, Peabody Orlando, 
lntemational Plaza Ba//room 
Sunday, March I.3 
Noon-5 p.m. 
Monday, March 19 
9 a.m.-S p.m. 
Tuesday, March 20 
9 a.m.-5 p.m. 
Wednesday, March 21 
9 a.m.-Noon 
Wednesday, March 21 
m 8:30 a.m.-l&W a.m. 
m The Trans-Atlantic 
Intersociety Consensus on the 
Management of Peripheral 
Arterial Disease, Ha//A3 
m 8:30 a.m.-l&00 a.m. 
m Risk Factors in Minority 
Populations, Room 230B 
1 .~+d &30 a.m.-l&00 a.m. 
m Lipid-Based Coronary 
Risk Assessment, Room 304E 
m 9:OO a.m.-l&00 a.m. 
w Management of 
Disorders of Triglyceride and 
HDL, Room 224E ml3 
m 4:W a.m.-1200 a.m. 
m Risk Factors for 
Atherosclerosis, /fc~//A4 
m 9:OO a.m.-1l:OO a.m. 
m Coronary Artery 
Disease and Various Pharma- 
cologic Agents, Ha// A4 
9:OO a.m.-1l:OO a.m. 
B Lipids: Miscellaneous, 
Ha// A4 
m %OOa.m.-1l:OOa.m. 
B Novel Biochemical 
Markers of Atherosclerosis, Ha// A4 
m lo:30 a.m.-ii:30 a.m. 
B Evaluating and 
Managing the Hypercoagulular 
State, Room 224E m 
m l&30 a.m.-1230 p.m. 
B ACC 2001 Meeting 
Highlights, Ha//E 
m lo:30 a.m.-Noon 
m Endothelial 
Dysfunction I, 
u):30 a.m.-Noon 
Coronary Disease Risk 
Factors, Room 2300 
m l2:l5 p.m.-k45 p.m. 
B How to Establish a 
Noninvasive Vascular Laboratory, 
Room 107 
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Sunday, March 18 
3330 p.m.-MO p.m. 
Acute Coronary 
m 9:09 a.m.-Noon 
B New Guidelines for 
nanagement of Unstable Angina 
nd Non ST-Elevation Myocardial 
nfarction, Room 304E 
m 9:OO a.m.-tWoa 
B Controlling 
temodeling After Completed 
nfarctions, Room 414C 
B Noon-200 p.m. 
B Moderated Poster 
jession., .Advances in the 
nterventional Management of 
qcute Myocardial Infarction, 
‘la/l A4 
Noon-200 p.m. 
Stabile lschemic 
Syndrome: Risk Factors and Risk 
Factor Modification I, Hall A4 
Noon-200 p.m- 
Ultrastructural 
Observations and Regulation of 
Apotosis, Hail A4 
Noon-200 p.m. 
Mechanisms Promising 
mproved Outcomes With 
jurgical Revascularization, Hal/A4 
Noon-ZOO p.m. 
Myocardial 
Jathogenetic Aspects in Acute 
Coronary Syndromes, Hall A4 
Noon-2~00 p.m. 
w Novel Pharmacological 
Treatments for Acute Myocardial 
Infarction, Ha// A4 
m 200 p.m.-!%00 p.m. 
ba Determining Prognosis 
After Myocardial Infarction, 
Room 474C 
3~00 p.m.-5:OO p.m. 
Stabile lschemic 
Syndromes: Plasma Markers and 
Prognostic Studies, Hall A4 
m 3:00 p.m.-S00 p.m. 
Lr;n Cardioprotection 
During Myocardial Infarction, 
Hall A4 
3:W p.m.*00 p.m. 
B Coronary 
Pathogenetic Aspects in Acute 
Coronary Syndromes, Hall A4 
m 550 p.m.-200 p.m. 
B Coronary 
Hemodynamics: The Basics, 
Room 414C 
Syndrome: Risk Factors and Risk 
Factor Modification II, Hall A4 
3:OO p.m.-MO p.m. 
Coagulation and 
Inflammation in Acute Myocardial 
Infarction: Basic Observations, 
Hall A4 
B 8:OO a.m.-%00 a.m. 
m Presidential Plenary 
ession, Hall E 
B 9:OO a.m.-lOzOO a.m. 
M Are We Performing 
bo Many Coronary Inter- 
entions?, Room 224C as 
9:OO a.m.-11:OO a.m. 
Stabile lschemic 
iyndrome: Oxidative Stress 
nsulin Resistance and 
nflammation, Hall A4 
9:OO a.m.-1l:OOa.m. 
Advances in Cardio- 
Resuscitation, Hall A4 
SiOOa.m.-1liOOa.m. 
Blood Risk Markers in 
icute Coronary Syndromes, 
id A4 
9~00 a.m.-ii:00 a.m. 
Fibrinolytic Advances 
tment of Acute 
9:OO a.m.-ii:00 a.m. 
B Myocardial 
Preservation: Experimental 
Insights, Hall A4 
w 99.5 a.m.-%30 a.m. 
N Business Meeting of 
he College, Room 23013 
9:15 a.m.-l&30 a.m. 
Featured Oral Abstract 
nsights Into Myocardial 
lemodeling, Valencia A 
w lo:30 a.m.-lk30 a.?. 
B Are Angiotensin 
ieceptor Blockers Better Than 
ACE-Inhibitors in Post-Infarct 
Remodeling?, Room 224C m 
m -&-=~;y; 
Acute Myocardial Infarction, 
Hall A3 
li:OOa.m.-1215 p.m. 
Acute Coronary 
Syndromes: Cardiac Markers in 
Risk Assessment and Manage- 
ment Decisions, Room 23UB 
ii:00 a.m.-l2A9 p.m. 
Stabile lschemic 
Syndrome: Clinical Aspects, 
Vdencia A 
Noon-200 p.m. 
B Stabile lschemic 
Syndrome: New Mechanical 
Therapies, Hall A4 
donday, March 19 
Noon-2:00 p.m. 
Measurement of 
lfarct Size and Myocardial 
rotection, Hall A4 
Noon-200 p.m. 
Surgical Strategies for 
‘atients With Heart Failure, 
iall A4 
NootGkOO p.m. 
B General Clinical Risk 
barkers in Acute Coronary 
iyndromes, Hall A4 
m 2:OO p.m.-%30 p.m. 
B Joint Symposium: 
European Society of Cardiology/ 
tmerican Colleae of Cardioloqy- 
Management 07 Acute -- 
Myocardial Infarction, Vu/en& A 
B 2:OO p.m.&30 p.m. 
m New Management 
Concepts of Acute Coronary 
jyndromes, Room 2300 
B 2~30 p.m.3:30 p.m. 
B Management of Right 
Jentricular Infarction and Shock 
luring Acute Myocardial 
nfarction, Room 224C #ii?4 
3~00 p.m.-W0 p.m. 
Treatment Strategies 
for Cardiac lschemic Syndromes, 
Ha// A4 
Noon-200 p.m. 
Myocardial Perfusion 
luring Acute Myocardial 
nfarction, Hall A4 
m l2AJ p.m.-i:45 p.m. 
B Diabetes and the 
Cardiologist: A Call to Action, 
Zoom 102 
3:OO p.m.-%00 p.m. 
Regulation of 
Angiogenesis and Coronary Flow 
in Myocardial Infarction, Hall A4 
3:OO p.m.-!%00 p.m. 
Stabile lschemic 
Syndrome: Medical Therapies, 
Hall A4 
3:OO p.m.-NlO p.m. 
Time to Treatment in 
cardial Infarction, 
3:OO p.m.-!%00 p.m. 
Specific Clinical Risk 
Markers in Acute Coronary 
Syndromes, Ha// A4 
Strategies for Managing Acute 
Myocardial Infarction, Room 2301 
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r  ruesday, March 20 7 
M 9130 a.m.4090 a.m. 
B New Insights in Plaque 
Arlnerability: Novel Imaging 
rechniques, Valencia D 
8:30a.m.-lOtO0 a.m. 
New Aspects of Clvco- 
lrotein Ilb/llla Inhibitors in Acute 
Coronary Syndromes, Room 230D 
4therosclerosis, Rook 2240 m 
9:OOa.m.-WOO a.m. 
Coronary Bypass 
3peration Without Extracorporeal 
Circulation, Hall A4 
9:00a.m.-1i:OOa.m. 
Myocardial 
‘reservation: Mechanistic 
nsights, Hall A4 
9:OO a.m.-ii:00 a.m. 
Stabile lschemic 
: Stress Testing and Risk 
Stratification, Hall A4 
9:OOa.m.~1liOOa.m. 
Novel Risk Markers 
and Therapeutic Interactions, 
‘-/cd/ A4 
9~00 a.m.-ii:00 a.m. 
Combination 
4pproaches to Treating Acute 
vlyocardial Infarction, Hal/A4 
-10:30a.m.-llc30a.m. 
B Should All Patients 
rNith an Abnormal Stress Imaging 
Study Undergo Coronary Arterio- 
graphy?, Room 2240 m 
m l&30 a.m.-Noon 
B joint Symposium: 
4merican College of Physicians- 
4merican Society of Internal 
Medicine/American College of 
Cardiology-Management of 
Chronic Stable Angina in Special 
Patient Groups, Room 330 
lo:30 a.m.-Noon 
Secular Trends in the 
Management of Acute Myocardial 
Infarction, Room 230D 
Noon-200 p.m. 
Stabile lschemic 
Pathophysiology, 
and Prognosis I, Hall A4 
Noon-200 p.m. 
Biochemical Alterations 
and Marker Release in the 
lschemic Myocardium, Hall A4 
Noon-230 p.m. 
Coronary Syndromes, Hall A4 
Noon-200 p.m. 
Complications of 
Acute Myocardial Infarction, 
YcI// A4 
m 200 p.m.400 p.m. 
m 32nd Annual Louis F. 
Bishop Lecture, Room 330 
m 200 p.m.430 p.m. 
w What Constitutes a 
Diagnosis of Myocardial 
Infarction in 2001?, Hall F4 
200 p.m.430 p.m. 
Evolving Parametrics 
of Quality of Life After 
4cute Coronary Syndromes, 
Valencia D 
m 2~30 p.m.3:30 p.m. 
B Management of 
Unstable Angina, Room 224F m 
3:OO p.m.-9Sll p.m. 
Outcome Predictors 
yocardial Infarction, 
300 p.m.-%00 p.m. 
Morbidity and Mortality 
With Surgical 
Revascularization, Hall A4 
300 p.m.400 p.m. 
Myocardial Infarction 
and Ischemia: Focus on Nitric 
Oxide and Coronary Flow, Hal/A4 
3~00 p.m.400 p.m. 
Stabile lschemic 
Syndrome: Pathophysiology, 
Diagnosis, and Prognosis II, 
Hall A4 
3:OO p.m.-9zOO p.m. 
Evolving Anti- 
thrombotic Approaches in Acute 
Coronary,Syndromes, Hal/A4 
m 400 p.m.400 p.m. 
m Clinical Assessment of 
Success of Repetfusion: Is It 
Possible?, Room 2240 aa 
m 4:OO p.m.400 p.m. 
m Experimental 
Therapies of Acute Myocardial 
Infarction, Hall f4 
bw 4:OO p.m.-%00 p.m. 
B Regulation of 
Angiogenesis in Myocardial 
lschemia and New Models,. 
Valencia D 
m B:OO p.m.+%?0 p.m. 
B 50th Annual 
Convocation, 
Peabody Orlando, lntemational 
Plaza Ballroom 
B Structured Sessions 
B (Black Boxes) 
B Abstract 9essions 
B (Crey Boxes) 
B Session Qpe and 
m Number are shown 
B in the shaded box. 
I1:h Refer to the 9cientttc 
Sessions Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The Session Tttle and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March l9 
Noon-5 p.m. 
Monday, March 19 
9 a.m.-5 p.m. 
lkesday, March 20 
9 a.m.-S p.m, 
Wednesday, March 21 
9 a.m.-Noon 
Wednesday, March 21 
w 8:30 a.m.-lOzOO a.m. 
m Stabile lschemic 
Syndrome: Mechanistic Insights, 
Valencia B 
w 9~30 a.m.-l&W a.m. 
m Advances in the 
Pharmacotherapy of Acute 
Myocardial Infarction, Room 23lA 
m 8:30 a.m.-l&00 a.m. 
- New Horizons for 
Surgical Myocardial 
Revascularization, Room 304A 
w 9~00 a.m.-lOzOO a.m. 
m Importance of 
Evaluating Left Ventricular Function 
in the Post-Myocardial Infarction 
Patient, Room 224C m 
9:OO a.m.-1l:OO a.m. 
w Trends in Acute 
Myocardial Infarction 
Management, Hal/A4 
%OOa.m.-lM0 a.m. 
Acute Coronary 
Syndromes: Clinical and 
Laboratory Predictors of 
Outcome, Hall A4 
w 9:OO a.m.-ii:00 a.m. 
m Myocardial Ischemia: 
Left Ventricular Structure and 
Function, Hall A4 
m 4:00a.m.-1i:OOa.m. 
m Stabile lschemic 
Syndrome: Pathophysiology, 
Diagnosis, and Prognosis Ill, 
Ha// A4 
m 9~00 a.m.-1l:OO a.m. 
m Defining Modalities of 
the Acute Coronary Syndromes, 
Hall A4 
m 1090 a.m.-1230 p.m. 
m ACC 2001 Meeting 
Highlights, Hall E 
w lo:30 a.m.-Noon 
m Limitation of Infarct 
Size: Novel Approaches, 
Room 230B 
Itlli.:llielr 12:lS p.m.-U5 p.m. 
m Angiotensin Receptor 
Blockers and Cardioprotection, 
Room 704 
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Sunday, March 18 
m 7~30 a.m.-%00 a.m. 
m Optimizing Perfusion 
Imaging in Everyday Practice, 
Room 330 
Hospital Practice of Nuclear 
Cardiology I: Reimbursement and 
Credentialing, Room 34UA 
a.m.400 a.m. 
m !zid With the 
Experts...Focus on Technical 
Artifacts: Preventing, identifying, 
and Modifying, Room 3408 
m ~?o~%?~~a p h y in 
Valvular Heart Disease, Valenciu A 
m 9~00 a.m.-IO:15 a.m. 
m Echocardiography in 
lschemic Heart Disease, Vu/en& D 
m 8:OO a.m.-Noon 
It;i Echocardiography in 
Congenital Heart Disease, 
Valencia 5 
Noon-200 p.m. 
Echo Assessment of 
the Left Atrium and lnteratrial 
Septum, Hall A4 
Noon-2:00 p.m. 
Cardiovascular 
m 230 p.m.430 p.m. 
m Assessing and 
Quantifying Left Ventricular 
Function and Volumes: Which 
Test When?, Room 340A 
Kq 2:30 p.m.3:30 p.m. 
m Read With the Experts. . . 
Difficult and Challenging Cases 
Magnetic Resonance: Plaque and 
Lumen, Ha// A4 
Noon-200 p.m. 
Refinina Risk 
Stratification in Pa‘fient Subsets, 
Hall A4 
Noon-Z:00 p.m. 
Intracardiac and 
Intravascular Ultrasound, Hal/A4 
Noon-200 p.m. 
Contrast 
Echocardiography and the 
Microcirculation, Hall A4 
Noon-P:00 p.m. 
Stress 
Echocardiography: Impact on 
Prognosis, Hall A4 
w 9~00 a.m.-lo:00 a.m. 
m Advances in 
Technology and Applications: The 
Next Few Years, Room 330 B 1:30 p.m.-3:45 p.m. 
B 9:OOa.m.-lOzOO a.m. U lntraoperative 
m The Office and Echocardiography, Vcder~ck~ A 
Hospital Practice of Nuclear B 1:30 p.m.4930 p.m. 
Cardioloav II: lmorovina m New Technoioaies. 
LaboratoTy Efficiency, Elective- Valencia D 
., , 
ness, and Potential, Room 340A 
m 9:OO a.m.-10:OO a.m. 
m Read With the 
Experts...Focus on Technique, 
Pitfalls, and Interpretation of 
Cated Single Photon Emission 
Computed Tomography, 
Room 3405 
M u):l5 a.m.-Noon 
m Diastology, Valencia D 
B l&30 a.m.-Noon 
m Applications in 
Coronary Artery Disease in 
Practice, Room 330 
m lo:30 a.m.-Noon 
m Comparing Programs 
for Quantitation of Perfusion and 
Function: A (Possibly) Friendly 
Debate, Room 340A 
m lo:30 a.m.-Noon 
m Read With the 
Experts...Reading Lots and Lots 
of Everyday Cases Along With the 
Experts, Room 3408 
B i:30 p.m.-5:30 p.m. 
U Interesting Case 
Studies, Vdencia 5 
m 1:30 p.m.430 p.m. 
m Optimizing Decision 
Making in Acute Coronary 
Syndromes, Room 330 
m 1:30 p.m.430 p.m. 
m Nuances of 
Optimizing Perfusion and 
Function Imaging Protocols, 
Room 340A 
From Everyday Practice, 
Room 3408 
300 p.m.-5:OO p.m. 
Echo Assessment of 
nd Global Function, 
3~00 p.mAOO p.m. 
Topics in Transeso- 
phageal Echo, Hall A4 
300 p.m.400 p.m. 
Assessina 
Pathophysiology inllschemic 
Heart Disease by Positron 
Emission Tomography, Ha// A4 
3:00 p.m.-k%00 p.m. 
Echocardiographic 
Assessment of Left Ventricular 
Mechanics, Hall A4 
300 p.m.-!%00 p.m. 
Echo Assessment of 
Viability: Predicting Outcome, 
Hall A4 
300 p.m.-!%00 p.m. 
Mvocardial Contrast 
Echocardiography in Acute 
Myocardial Infarction I, Hal/A4 
bx 3:4!i p.m.5:30 p.m. 
m Transesophageal 
Echocardiography, Vdencia A 
m 4:OO p.m.5:30 p.m. 
m Stump the Stars: 
Unknown Challenges Presented 
to Experts and Attendees, 
Room 330 
m k30 p.m.-2:30 p.m. 
m Read With the 
Experts...Understanding and 
Applying Filtering and Attenuation 
Correction, Room 3408 
B 2~30 p.m.*30 p.m. 
m Advances in Managing 
Coronary Artery Disease/Left 
Ventricular Dysfunction, 
Room 330 
m 5:30 p.m.-R00 p.m. 
m Advances in Contrast 
Echocardiography, Valencia D 
m 5:30 p.m.+00 p.m. 
m Noninvasive 
Evaluation of Heart Disease in 
Women, Vdencia A 
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Abstract Sessions 
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are listed next. All rooms are in 
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m Some sessions require a 
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Monday, March 19 
9 a.m.-5 p.m. 
Tuesday, March 20 
9 a.m.-5 p.m. 
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9 a.m.-Noon 
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Monday, March 19 
w f&O0 am.-9iOO a.m. 
m Presidential Plenary 
Session, Ha// E 
m 900 a.m.-lo:00 a.m. 
m Clinical Applications of 
‘ositron Emmision Tomography, 
Poom 2246 m 
-4:OOa.m.-lOi00 a.m. 
M Cardiac Magnetic 
Resonance Imaging: Dobutamine 
Stress Testing, Room 224H m 
w 9~00 a.m.-llS0 a.m. 
m Coronary Artery 
Doppler, Ha//A4 ’ I 
900 a.m.-l&00 a.m. 
Cardiovascular 
Magnetic Resonance: imaging 
the Left Ventricle, Hall A4 
9~00 a.m.-1l:OO a.m. 
Optimizing Assessment 
lar Function: Advances 
in Radionuclide Techniques 
9:OO a.m.-l&O0 a.m. 
Echo Assessment of 
Right Ventricular Infarction, 
Hall A4 
Echocardiography: Protocol 
Refinements, Hall A4 
m 9:OO a.m.-ii:00 a.m. 
Myocardial Contrast 
Echocardiography in Acute 
Myocardial Infarction II, Hall A4 
m 9d.5 a.m.-%30 a.m. 
m Business Meeting of 
the College, Room 230B 
m 9:l5 a.m.-1010 a.m. 
m Echocardiographic 
Assessment of Atrial Fibrillation 
and Source of Embolus, 
Vdeflcia 8 
~10:30a.m.-llz30a.m. 
m Cardiovascular Issues 
in Manned Space Flight, 
Room 224 E m 
-10:30a.m.-lli30a.m. 
Ip! Cardiac Magnetic 
Resonance Imaging: Viability 
Assessment, Room 2246 m 
~11:OOa.m.-12~15 p.m. 
m Advances in the 
Evaluation of Regional Myocardial 
Function, Valencia D 
w 1lzOO a.m.-l2z15 p.m. 
m Stress Echo- 
:ardiography: Risk Stratification, 
Valencia B 
11:OO a.m.429.5 p.m. 
Cardiovascular 
Llagnetic Resonance: Imaging 
‘laque, Thrombus, and Ischemia, 
Room 4 14A 
Noon-200 p.m. 
Strain-Rate Imaging, 
Hall A4 
Noon-200 p.m. 
Stress Perfusion 
Imaging Following Percutaneous 
Intervention and Acute Coronary 
Three-Dimensional 
Imaging of Valvular Heart 
Disease, Ha// A4 
Noon-200 p.m. 
Echo Doppler 
Assessment of Vascular Disease, 
Ha// A4 
Noon-200 p.m. 
Pharmacologic and 
tress Echo, Hall A4 
Noon-?:00 p.m. 
New Insights Into the 
Microcirulation Using Contrast 
Echocardiography, Hall A4 
w 1215 p.m.-i:45 p.m. 
m Stress Echo- 
cardiography, Room 105 
w 200 p.m.3:30 p.m. 
m Prognostic Assessment 
After Myocardial Infarction, 
Valencia D 
200 p.m.*30 p.m. 
Myocardial Contrast 
Echocardiography: New 
Developments, Valencia B 
w 230 p.m.430 p.m. 
m Evaluation and 
Management of Prosthetic Valve 
Dysfunction, Room 224H m 
3~00 p.m.*00 p.m. 
Moderated Poster 
Session...New Doppler 
Techniques I, Hall A4 
w 3:00 p.m.-500 p.m. 
B Contrast Echo- 
:ardiography, Hall A4 
B 390 p.m.-500 p.m. 
B Nuclear Cardiology: 
idvances in Stress Agents, 
Tracers, and Techniques, Hall Ad 
B 3~00 p.m.-!%00 p.m. 
B Electron-Beam 
lomputed Tomography: 
loronary Calcification-Gender, 
Genetics, and Pretest Likelihood, 
Yall A4 
B 3:00 p.m.-%00 p.m. 
w Echo Assessment of 
:he Left Atrium, Hall A4 
w WO p.m.5:OO p.m. 
B ldentifvina Viable 
vlyocardium With Echo- 
cardiography, Hall A4 
w a:00 p.m.*00 p.m. 
B Myocardial Contrast 
Echocardiography for Coronary 
Stenosis Detection, Hall A4 
B 400 p.m.5:OO p.m. 
Liv Miniaturization in 
Echocardiography: Are These 
Studies Diagnostic?, 
Room 224 H a!& 
w 4:00 p.m.-5580 p.m. 
B Contrast Echo- 
cardiography: New Develop- 
ments, Valencia B 
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B Session Type and 
m Number are shown 
B in the shaded box. 
m Refer to the Scientific 
Sessions Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The Session Title and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
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Ituesday, March 20 
B 8:30 a.m.-lOi00 a.m. 
m Magnetic Resonance 
maging in lschemic Heart 
Disease, Vale&a A 
8~30 a.m.-l&00 a.m. 
Echo-Doppler indices 
If Ventricular, Valvular, and 
Jascular Function, Valencia 5 
B 9:OO a.m.-M:00 a.m. 
B How to Use Doppler 
Techniques to Evaluate Diastolic 
Gnction, Room 224 aa 
B 9.M a.m.-IO:00 a.m. 
m Post Myocardial 
nfarction Assessment: Aggressive 
>r Conservative?, 
Room 2246 @a 
B 9:W a.m.-ii:00 a.m. 
m Echocardiography: 
Vliscellaneous, Ha//A4 
9:OO a.m.-li:OO a.m. 
Perfusion, Metabolism, 
and Neural Function in lschemic 
and Other Cardiomyopathies: 
Radionuclide Techniques, 
Hall A4 
9100 a.m.-WOO a.m. 
m Three-Dimensional 
Echocardiography in Nonvalvular 
Heart Disease, Hull A4 
9:OO a.m,-1l:OO a.m. 
Echo Assessment of 
Novel Surgical Devices, Hal/A4 
9:OO a.m.-ii:00 a.m. 
m Detection of 
Myocardial Viability, Ho//A4 
900 a.m,-ii:00 a.m. 
m Myocardial Contrast 
Echocardiography for Assessing 
Blood Flow Reserve, Ha// A4 
B l&30 a.m.-l&30 a.m. 
m Attenuation 
Correction: Needed or Not?, 
Room 224 C nB 
B l&30 a.m.-Noon 
m Noninvasive 
Assessment of Myocardial 
Viability, Valencia A 
lo:30 a.m.-Noon 
Featured Oral Abstract 
Session...Advances in Nuclear 
Cardiology: Bench to Outcomes, 
Room 4 14A 
lo:30 a.m.-Noon 
Three-Dimensional 
Echocardiography, Room 4 14C 
Noon-200 p.m. 
Quantitative 
Myocardial Perfusion Imaging, 
Hall A4 
NoonP:OO p.m. 
Computed 
Tomography/Magnetic 
Resonance Imaging: Coronary 
Calcification-Risk and Correlates, 
Hall A4 
Noon-kW p.m. 
Refinina Risk 
Stratification: Global Scores and 
Beyond, Ho// A4 
Noon-200 p.m. 
Topics in Clinical 
Echocardiography, Hall A4 
Noon-200 p.m. 
Stress Echo- 
cardiography: Coronary Flow 
Reserve and Ischemia, Hal/A4 
Noon-200 p.m. 
Contrast 
Echocardiography Imaging 
Parameters, Ho/l A4 
B I.215 p.m.-i:45 p.m. 
m Echocardiography in 
Acute Myocardial Infarction, 
Room 107 
300 p.m.-590 p.m. 
Cardiovascular 
Resonance: Flow 
Reserve, Viability, and Safety, 
Hall A4 
3:00 p.m.400 p.m. 
Assessing lschemia 
and Coronary Artery Disease: 
Implications for Decision Making 
and Outcomes, Hall A4 
300 p.m.-5:W p.m. 
Clinical and 
Experimental Echo Studies in 
Diastolic Function, Ho// A4 
Hall A4 
3:W p.m.*00 p.m. 
Dobutamine Stress 
ellaneous Applications,, 
300 p.m.&00 p.m. 
Myocardial Contrast 
Echocardiography: Real-Time 
imaging, Hall A4 
Echocardiography for Myocardial 
Perfusion: How to Get Started, 
Room 2246 m 
m 4:OO p.mAOO p.m. 
P;r Prediction of Viability 
in Chronic Coronary Disease, 
Auditorium 
4:W p.m.-i%00 p.m. 
Computed 
by/Magnetic 
Imaqinq: lschemic 
w 200 p.mAOO p.m. 
m 32nd Annual Louis F. 
Heart Disease, ~~/&a B 
Bishop Lecture, Room 330 
3200 p.m.-3:30 p.m. 
Stress Echo- 
cardiography: Doppler 
Applications, Room 414A 
Assessment of Myoca?dial 
Viability, Room 414C 
Digital Echocardiography Lab, 
Room 224 E EN 
mm 
230 p.m.-3:30 p.m. 
Stress Echocardio- 
graphy: What to Do and What 
Not to Do, Room 2246 ax 
3~00 p.m.400 p.m. 
New Doppler 
Techniques II, Hall A4 
m 5:30 p.m.-EM) p.m. 
B Noninvasive Screening 
for Atherosclerosis, Valencia B 
m 930 p.m.400 p.m. 
B Advances in Nuclear 
Cardiology: Thrombus, 
Receptors, Rejection, Hypoxia, 
Room 4 74A 
m 6:OO p.m.400 p.m. 
B 50th Annual 
Convocation, Peabody Orlando, 
International Plaza Ballroom 
Wednesday, Maxch 21 
8:30 a.m.-U):W a.m. 
Regional Function 
ith Tissue Doppler, 
loom 4 14A 
8:30a.m.-1O:OOa.m. 
Assessment of 
I Blood Flow in Disease 
jtates by Nuclear Imaging 
9:OO a.m.-&i:00 a.m. 
Echocardiography and 
9~00 a.m.-li:OO a.m. 
Detecting Coronary 
Artery Disease and Ischemia: 
fracers and Techniques, 
Ycdl A4 
9:OO a.m.-1l:OO a.m. 
Computed 
by/Magnetic 
7esonance Imaging: Coronary 
maging, Perfusion, Disease 
Applications, Hall A4 
9:00a.m.-1i:OOa.m. 
Stress Echocardio- 
graphy and Prognosis, Ho/l A4 
9:00a.m.-1l:OOa.m. 
Left Ventricular Cavity 
Opacification With Microbubbles, 
Ha// A4 
9:00a.m.-1l:OO a.m. 
Regional Function 
Assessment With Echocardiography, 
Hall A4 
B lo:30 a.m.-1230 p.m. 
B ACC 2001 Meeting 
, Hall E 
l&30 a.m.-Noon 
Myocardial Contrast 
Echocardiography in Coronary 
Artery Disease, Room 4 74C 
m l3:l5 p.m.445 p.m. 
m Myocardial Contrast 
Echocardiography, Room 7 095 
xx 
Sunday, March 18 
B 300 a.m.-Noon 
Role of and Advances 
in Catheter Interventions, 
Room 4 14A 
Noon-200 p.m. 
Advances in Nonin- 
vasive Imaging for Congenital 
Heart Disease, Ha// A4 
Ioy 2:OO p.m.-%00 p.m. 
m Advances in 
Congenital Heart Disease 
imaging, Room 4 14A 
3:OO p.m.490 p.m. 
New 
Echocardiographic Methods and 
Observations for Pediatric and 
Fetal Echocardiography, 
Hall A4 
m 5:30 p.m.+00 p.m. 
LAO. Late Fontan Patients 
and Their Problems, Room 330 
Monday, March 19 
B 8:OO a.m.400 a.m. 
m Presidential Plenary I 
Session, Hall E 
*OOa.m.-ii:00 a.m. 
Moderated Poster 
rogress in the 
Management of Congenital 
OS0 a.m.-1l:OO a.m. 
Heart Disease: Electrophysiologic 
and Anatomical Structural Issues, 
Ha// A4 
m 0% a.m.430 a.m. 
m Business Meetina of I#1 
d the College, Room 230B 
B M.5 a.m.-l&30 a.m. 
m Atrial Septal Defect in 
Adults, Room 2300 
w 1i:OO a.m.-1235 p.m. 
m Advances in the 
Genetics of Congenital Heart 
Disease, Room 2300 
eart Drsease: Followup and 
Newer interventional Strategies, 
Ha// A4 
m l235 p.m.&45 p.m. 
B Pediatric Telemedicine, 
Room 703 
200 p.mA30 p.m. 
Interventional 
ation: Strategies for 
Congenital Heart Disease, 
Room 4 7 4A 
300 p.m.S:OO p.m. 
Myocarditis: Systemic 
and Pulmonary Hypertension in 
Children and Adults, Ha// A4 
m 4:OO p.m.-%00 p.m. 
B Indications for and 
Use of implantable Defibrillators 
in Pediatric Patients, 
Room 224C m 
m 4200 p.m.5:00 p.m. 
B Transcatheter Patent 
Ductus Arteriosus Closure 
Methods, Room 2246 m 
m 4:OO p.m.430 p.m. I., 
B Adult Congenital 
Heart Disease: Followup and 
Outcomes, Room 4 14A 
B Structured Sessions 
B (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
B Session Fype and 
m Number are shown 
in the shaded box. 
Refer to the Scientific 
Sessions Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The Session Title and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 18 
Noon-5 p.m. 
Monday, March 19 
9 a.m.-S p.m. 
Tuesday, March 20 
9 a.m.-5 p.m. 
Wednesday, March 21 
9 a.m.-Noon 
xxi 
Tuesday, March 20 
3~30 a.m.-10:OOa.m. 
Featured Oral Abstract 
essron...Advances in Surgery for 
Congenital Heart Disease, 
Room 4 14/I 
m 5~00 a.m.-10:OO a.m. 
v Uses of and Indications 
For Coumadin in Fontan Patients, 
m 
00 a.m.-WOO a.m. 
ardiomyopathy and 
Congenital Heart Disease: Access, 
Followup, and Quality of Life, 
Ha// A4 
~10:30a.m.-llz30 a.m. 
m Management of 
Infants With Tachycardia, 
Room 224C 
I$:(lsi(10:30 a.m.-ii:30 a.m. 
m Management of 
Complex Left Ventricular Out 
Flow Tract Obstruction, 
Room 224 H ma 
m lo:30 a.m.-Noon 
m Controversies in 
Pediatric Cardiology, Valencia D 
Nom1400 p.m. 
Congenital Heart 
Disease: Adult and Pediatric 
Interventional Catheterization and 
Electrophysiology, Hall A4 
m 12~15 p.m.445 p.m. 
B Follow-Up Results in 
Young Adults Post-Operative 
Arterial Switch, Room 707 
m 2:00 p.mAOO p.m. 
w 32nd Annual Louis F. 
Bishop Lecture, Room 330 
m 200 p.m.430 p.m. 
m Pathwavs for 
Monitoring and Advancing 
Congenital Heart Disease Care, 
Room 2300 
m 2~30 p.m.430 p.m. 
m Strategies for Treating 
Post-Operative Patients With 
Decreased Cardiac Output, 
Room 224 H m 
3~00 p.m.-5:00 p.m. 
Congenital Heart 
Disease: Surgery Results and 
Followup Considerations, 
Hall A4 
m 4:OO p.m.5:00 p.m. 
B Kawasaki Disease 
Management, 
Room 224 H m 
m 400 p.m.400 p.m. 
m Advances in 
Management of Pulmonary 
Hypertension, Room 2300 
m $30 p.m.-?:00 p.m. 
B Management of 
Pulmonary Atresia/Ventricular 
Septal Defect, Room 2305 
m 530 p.m.400 p.m. 
B Special Problems in 
Adult Congenital Heart Disease, 
Room 230D 
m 6:OO p.m.-&00 p.m. 
m 50th Annual 
Convocation, Peabody Orlando, 
international Plaza Ballroom 
Wednesday, March 21 
8:30a.m.-l&00 a.m. 
m End-Staqe Adult 
Congenital Heart Disease 
Management, Room 2300 
9~00 a.m.-1l:OO a.m. 
Pediatric Cardiology: 
Experimental and Molecular 
Mechanisms, Hall A4 
m lo:30 a.m.-1230 p.m. 
m ACC 2001 Meeting 
Highlights, Hall E 
l&30 a.m.-Noon 
Heart Disease in 
Neonates and Infants Surgical 
Followup and Natural History, 
Room 4 74A 
Coarctation: Late 
Sequelae in the Young Adult, 
Room 701 
B Structured Sessions 
B (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
B Session lype and 
M Number are shown 
in the shaded box. 
Refer to the Scientific 
Seeelons Key for more information 
about the type of session. Oral 
and Poster Abstract Sessions are 
grey shaded boxes; Structured 
Sessions are shown in black. 
The Session Tile and its Location 
are listed next. All rooms are in 
the Orange County Convention 
Center unless otherwise noted. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 18 
Noon-5 p.m. 
Monday, March 19 
9 a.m.-5 p.m. 
Tuesday, March 20 
9 a.m.-5 p.m. 
Wednesday, March 21 
9 a.m.-Noon 
xxii 
Sunday, March 18 
9~00 a.m.Hoon 
m Valvular Heart Surgery: 
Current Standards and Novel 
\pproaches, 
Room 304A 
B Noon-ZW p.m. 
m Valvular Heart Disease: 
New Concepts, 
tiallA4 
B 3:OO p.m.400 p.m. 
m Observations in 
Cardiac Surgery, 
k1llA4 
B 5:30 p.m.400 p.m. 
Im Valve Disease in 
‘regnancy, 
Poem 304E 
Monday, March 19 
m 8:OO a.m&OO a.m. 
m Presidential Plenary , I 
Session, Hall E 
m 9:OO a.m.-lk00 a.m. 
m Etiology of Aortic 
Valve Stenosis, Ha// A4 
1;11$*r 035 a.m.-*30 a.m. 
m Business Meeting of 
the College, Room 2308 
m 9% a.m.-10:30 a.m. 
m Valvular Heart Disease: 
From Bench to Bedside, 
Valencia D 
B 9~15 a.m.-10:30 a.m. 
m Cardiac Surgery: 
Novel Observations and 
Approaches, Room 4 74A 
w 10:30a.m.-llt30a.m. 
m Asymptomatic Valve 
Disease: How Best to Manage, 
Room 224 H am 
m Noon-200 p.m. 
m Moderated Poster 
Session...lssues in Clinical Cardiac 
Surgery, Hull A4 
B Noon-200 p.m. 
m Valvular Regurgitation: 
Anatomic Functional Correlates, 
Hall A4 
B l333 p.m.-@IS p.m. 
uli Case Studies of Mitral 
Regurgitation, Room 7096 
B l!%l3 p.m.-M5 p.m. 
EI! Case Studies of Aortic 
Stenosis, Room 7 708 
B 200 p.m.430 p.m. 
m New Directions in 
Surgical Management of Valve 
Disease, Hall F3 
m 230 p.m.*30 p.m. 
m Echocardioaraahic 
Approach to Selection‘bf ‘Patients 
for Mitral Valve Repair, 
Room 2246 m 
3~00 p.m.-%00 p.m. 
Aortic Valve Stenosis, 
Hall A4 
Tuesday, March 20 
m 8:30a.m.-lOi00 a.m. 
m Featured Oral Abstract 
Session.. .Aortic Sclerosis Is Not 
Benign, Room 4 74C 
m 9:OO a.m.-10:OO a.m. 
B Case Studies in 
Valvular Disease: Aortic Stenosis 
and Low Output, 
Room 224 B #a 
m Noon-200 p.m. . I  
B Mitral Valve 
Regurgitation, Hall A4 
m 2:OO p.m.400 p.m. 
B 32nd Annual Louis F. 
Bishop Lecture, Room 330 
m 2:W p.m.430 p.m. 
B Sesion Conjunta con 
la Sociedad Interamericana de 
Cardiologia/Sociedad Espanola de 
Cardiologia/American College of 
Cardiology-Problemas,Relevantes 
en Cardiologia: 2001, Wench B 
m 230 p.m.J:lO p.m. 
B Quantification of 
Regurgitant Severity: A Practical 
Approach, Room 224C lil(pI 
m 3:W p.m.400 p.m. 
e Aortic Regurgitation, 
m 4:W p.m.400 p.m. 
B Diet Drugs: Lessons 
Learned, Ho// A3 
m 4:OO p.m.400 p.m. 
B Changing Indications 
for Surgical Intervention in 
Patients With Valvular Heart 
Disease, Volencia A 
m 400 p.m.400 p.m. 
B Molecular and Cellular 
Alterations in Chronic Valvular 
Regurgitation, Room 474A 
m 5:30 p.m.-R00 p.m. 
B lschemic Mitral 
Regurgitation: Medical and 
Surgical Management, 
Room 474C 
6~00 p.m.-%00 p.m. 
Convocation, Peabody Orlando, 
international Plaza Ballroom 
Wednesday, March 21 
m 9~00 a.m.-10:OO a.m. 
m Role of Transesophageal 
Echocardiography in Valve 
Surgery, Room 2246 aa 
B 900 a.m.-l&O0 a.m. 
m Mitral Valvuloalastv. 
Hall A4 
I  2, 
w lOS0 a.m.4230 p.m. 
m ACC 2001 Meeting 
Highlights, Ha//E 
bx lo:30 a.m.-Noon 
w Natural History of 
Valvular Heart Disease, 
Room 23 7A 
. . . 
XXIII 
Sunday, March 18 
B 8:OO a.m.-9:OO a.m. . . .Adobe Photoshop: Basics, 
m Pericardial Disease, Booth 3 163, Classroom 2 m 
Auditorium 
B 9:00a.m.-10:OO a.m. 
m Aortic Dissection, 
Auditorium 
B 1O:OO a.m.-&k00 a.m. 
v Acute Mvocardial 
Infarction, Auditor&n 
2~30 p.m,3:30 p.m. 
Acute Coronary 
Syndromes, Auditorium . 
v 300 p.m.b:OO p.m. 
w Moderated Poster 
Session...Outcomes Research in 
Cardiac Surgery, Hall A4 
1kOO a.m,-Noon 
Chronic Coronary 
Arterv Disease. Auditorium , 
-4 300 p.m.b:OO p.m. 
Applications in Cardiology: 
Neural Networks and Virtual 
w Moderated Poster 
Session.. .Advanced Computer 
m Noon-2:00 p.m. 
w 18th Annual 
Symposium for Directors of 
Reality, Hull A4 
B 3:OO p.m.-b:00 p.m. 
m Computers in 
Cardiology I: Imaging and 
Diagnosis, Hall A4 
Pediatric Cardiology Programs 
(Luncheon), Room 106 
Symposium for Directors of Adult 
Cardiology Training Programs 
(Luncheon), Room 300 
m 3:30 p.m.-4:30 p.m. 
m Heart Failure, 
Auditorium 
B 3:30 p.m.-4iSO p.m. 
m info@ACC 
Theater...Voice Recognition, 
Booth 3 163 
m Noon-2~00 p.m. 
m Outcomes Research: 
Quality of Life Studies, Hall A4 
B 3:SO p.m.-5:00 p.m. 
m info@ACC 
Classroom...Quicken 2000, 
Booth 3 7 63, Classroom 7 m 
. ..Web Site Basics: How to 
Build Your Own Web Site Using 
FrontPaae 2000. 
Booth 3 Ti3, ?ias\room 2 s 
B 4:30 p.m.5:30 p.m. 
v Valvular Heart Disease, 
Auditorir~m 
Theater...Handheld Computing, 
Booth 3 7 63 
=gfg p&~~;;;;~., 
. ..Microsoft PowerPoint 2000: 
Basics, 
Booth 3 163, Classroom 7 ns 
8Fm 
12:30 p.m.d:OO p.m. 
info@ACC Classroom 
. ..Windows 2000: Basics, 
Booth 3 163, Classroom 2 m 
v 1:SO p.m.-Z30 p.m. 
~B Preventive Cardiology, 
Auditorium 
Wireless Communications, 
Booth 3 I63 za 
m 2:00 p.m.+30 p.m. 
B info@ACC Classroom 
. . .Windows 2000: Basics, 
Booth 3 7 63, Classroom 7 m 
Monday, March 19 
m 5~00 a.m.-W0 a.m. 
m Presidential Plenary 
Session, Ha// E 
m 9:00a.m.USO a.m. 
m Outcomes Research in 
Special Populations, Hall A4 
m WO a.m..lZ:SO p.m. 
B Computer Applica- 
tions...Electronic Record and 
Clinical Trials, Booth 3 7 63 
Computerized Medical Solutions: 
How to Use Computerized Tools 
to Improve Patient Outcomes, 
Booth 3 7 63 
B 9:OO a.m.-1O:SO a.m. 
B info@ACC Classroom 
. ..Microsoft Office 2000, 
Booth 3 7 63, Classroom 7 ml! 
m 9:OOa.m.~10~30 a.m. 
B info@ACC Classroom 
. ..The Internet Today, 
Booth 3 7 63, Classroom 2 m 
m B~l.5 a.m..9:30 a.m. 
B Business Meeting of 
the College, Room 230B 
=J# 
9:l!Ja.m.-lOtSO a.m. 
Late Breaking Clinical 
Trials I, Ha// E 
m 9% a.m.-10:SOa.m. 
m Improving the Quality 
of Cardiovascular Care: Strateaies 
for Improving Medical Errors, d 
Room 474C 
m 9:30 a.m.-10:SOa.m. 
B Controversies in 
Cardiology I, Room 230B 
m lo:30 a.m.-Noon 
B info@ACC Classroom 
. ..Adobe Photoshop: Basics, 
Booth 3 7 63, Classroom 7 BE 
m lOS30 a.m.-Noon 
w info@ACC Classroom 
. . . Microsoft Office 2000, 
Booth 3 7 63, Classroom 2 m 
IcTil;(lll ii:00 a.m.-%?A5 p.m. 
m ABIM Town Meeting: 
A Discussion of Certification and 
Beyond, Auditorium 
m 11:OO a.m.-l&l5 p.m. 
B Young Investigators 
Awards Competition: Physiology, 
Pharmacology, and Pathology, 
Room 4 74C 
m 11:OO a.m.-Noon 
m info@ACC Theater.. . 
DICOM, Booth 3 163 
B Noon-P:00 p.m. 
B Comouters in 
Cardiology II: Imaging and 
Diagnosis, Ha//A4 
I.255 p.m.-i:45 p.m. 
Women in Cardiology 
Committee Special Lunchtime 
Session: Professional Skills 
Development-Negotiation and 
Conflict Resolution, Room 706 
m ;f$oPoPA;L;‘;~;$r,. 
Medline/Pub Med, Booth 3163 
m 12:30 p.m.&00 p.m. 
m info@ACC Classroom 
. ..Microsoft Access 2000, 
Booth 3 7 63, Classroom 1 a!s 
m 12:SO p.m.-2:OO p.m. 
B info@ACC 
Classroom.. .Microsoft 
PowerPoint 2000: Basics, 
Booth 3763, Classroom 2 m 
B ZSO p.m.-J:30 p.m. 
m Computer Applica- 
tions...Database Applications in 
Cardiology, Booth 3 7 63 
6 ZOO p.m.-5:SO p.m. 
m Controversies in 
Cardiology II, Auditorium 
m 2X80 p.m.-S:30 p.m. 
M Youno lnvestiqators 
Awards Competition: Molecular 
and Cellular Cardiology, 
Room 474C 
m 200 p.m..3:30 p.m. 
m Featured Oral Abstract 
Session...Outcomes Research: 
Key Studies From Large 
Databases in Coronary Artery 
Disease, Room 304f 
m 200 p.m.-3:OO p.m. 
m info@ACC Theater.. 
Digital Imaging Technology, 
Booth 3 7 63 
B 2:00 p.m.-3:30 p.m. 
Lp;f infc@ACC 
Classroom...Microsoft 
PowerPoint 2000: Advanced, 
Booth 3 7 63, Classroom 7 #ifl 
B 2~00 p.m.+30 p.m. 
m info@ACC Classroom 
. . .QuickBooks Pro 2000, 
Booth 3 7 63, Classroom 2 m 
m 300 p.m&OO p.m. 
bm Population Based 
Studies of Coronary Heart 
Disease, Ha// A4 
Handheld Computing, 
Booth 3 163 
Classroom.. .GB Stat, 
Booth 3 163, Classroom 7 m 
m 3:SO p.m.-J:00 p.m. 
B info@ACC Classroom 
. ..Windows 2000: Advanced, 
Booth 3 163, Classroom 2 m 
l1l$rlr 4~00 p.m.+30 p.m. 
B Young Investigators 
Awards Competition: Clinical 
Investigations, Room 4 74C 
xxiv 
r  ruesday, March 20 
m'3i30a.m.~10:OOa.m. 
B Late Breaking Clinical 
rrials II, Ha// E 
w 5~30 a.m.-Noon 
B Controversies in 
Iardiology Ill, Auditorium 
800 a.m.-ii:00 a.m. 
Outcomes Research 
n Percutaneous Coronary 
ntervention and Acute Coronary 
Syndromes II, Ha// A4 
w 0~00 a.m.-l230 p.m. 
B Computer Applica- 
:ions...Clinical Cardiology: Care 
at a Distance, 600th 3763 
m 9:OO a.m.-l&30 a.m. 
B info@ACC Theater.. . 
nternet-Empowered Consumers: 
Their Effect on Healthcare, 
Booth 3 7 63 
m 9:OOa.m.~IO:30 a.m. 
m info@ACC Classroom 
. ..Microsoft Access 2000, 
Booth 3 7 63, Classroom 7 m 
m 9:OOa.m.~10:30 a.m. 
B info@ACC 
Classroom...Web Site Basics: 
How to Build Your Own Web Site 
Using FrontPage 2000, 
Booth 3 7 63, Classroom 2 m 
m lo:30 a.m.-llB0 a.m. 
B Assessing and 
Managing Cardiac Risk of 
Noncardiac Surgery, 
Room 224 E aa 
m lo:30 a.m.-Noon 
m Clinical Decision 
Making, Hall F3 
m lo:30 a.m.-Noon 
B Why My Diet Is the 
Best, Valencia B 
m lo:30 a.m.-Noon 
B info@ACC Classroom 
. ..Windows 2000: Advanced, 
Booth 3 7 63, Classroom 7 m 
Classroom...The Internet Today, 
Booth 3 7 63, Classroom 2 #a 
m ii:00 a.m.-Noon 
B info@ACC Theater.. . 
Wireless Communications, 
Booth 3 7 63 
I 
I 
i I 
,I 
w Noon.i:45 p.m. 
m The Bristol-Myers 
Squibb A-I-T Forum and Luncheon, 
Rosen Centre, Grand Ballroom D 
Noon-P:00 p.m. 
Outcomes Research in 
4cute Myocardial Infarction and 
Coronary Heart Disease, 
Ha// A4 
m 13% p.m.~i:43 p.m. 
m The World Wide Web 
in Cardiology, Room 706 
m l230 p.m.-i:30 p.m. 
B info@ACC Theater... 
Hands-On Palm, Booth 3 7 63 
w -30 p.m.&00 p.m. 
m info@ACC 
Classroom...Quicken 2000, 
Booth 3 7 63, Classroom 7 m 
m 1230 p.m.-P:00 p.m. 
m info@ACC Classroom 
. .Microsoft PowerPoint 2000: 
Advanced, 
Booth 3 7 63, Classroom 2 m 
m k30 p.m.-5:OO p.m. 
B Computer Applica- 
tions...Computer Applications in 
Echocardiography, Booth 3 7 63 
m 200 p.m.-3:OO p.m. 
w 32nd Annual Louis F. 
Bishop Lecture, Room 330 
m 200 p.m.&30 p.m. 
m Advances in Cardio- 
vascular Surgery: Valves, Stent 
Grafts, and Robots, Valencia A 
200 p.mA30 p.m. 
Outcomes Research 
in Percutaneous Coronary 
Intervention and Acute Coronary 
Syndromes I, Room 237A 
m 200 p.m.-3:OO p.m. 
m info@ACC Theater... 
Photoshop and Software 
Solutions, Booth 3 7 63 
m 200 p.m.-3:30 p.m. 
w info@ACC Classroom 
. ..Adobe Photoshop: Basics, 
Booth 3 7 63, Classroom 7 m 
m 200 p.m.-330 p.m. 
m info@ACC Classroom 
. ..Microsoft Office 2000, 
Booth 3 7 63, Classroom 2 
B 300 p.m.-5:OO p.m. 
B Outcomes Research in 
Congestive Heart Failure, Hall A4 
B 3:30 p.m.-49 p.m. 
B info@ACC Theater... 
XCOM, Booth 3 763 
B 3:30 p.m.-5:OO p.m. 
B info@ACC Classroom 
..Microsoft PowerPoint 2000: 
idvanced, 
300th 3763, Classroom 7 m 
w 3:30 p.m.-900 p.m. 
B info@ACC Classroom 
..QuickBooks Pro 2000, 
Booth 3 7 63, Classroom 2 m 
Clinical Outcomes From the 
ACC-National Cardiovascular 
Data Registry, Room 2306 
m 400 p.m.-5:OO p.m. 
w 32nd Annual Bethesda 
Conference Report: Care of the 
Adult Survivor With Congenital 
Heart Disease, Room 474C 
m 400 p.m.-5:OO p.m. 
B Controversies in 
Cardiology IV, Ha// F3 
Association.of Black Cardiologists/ 
American College of Cardiology- 
Findings and Recommendations 
of the Joint Committee on Ethnic 
and Gender Disparities in Access 
to Quality Cardiovascular Care, 
Room 304E 
m 5:30 p.m.-R00 p.m. 
B Tax and Estate 
Planning to Further Personal and 
Philanthropic Goals, Hall A3 
m B:OO p.m.-&00 p.m. 
w 50th Annual 
Convocation, Peabody Orlando, 
international Plaza Ballroom 
iV&lnesday, March 21 
B 8:30 a.m.-10:OO a.m. 
B Late Breaking Clinical 
rrials III, Hall E 
w 9:00a.m.4liOOa.m. 
Outcomes Research in 
Special Populations: Arrhythmias, 
Syncope, and Aortic Dissection, 
Ha// A4 
w 5~00 a.m.-Noon 
m Comouter Applications.. 
Computers in Cardiology, ‘Booth 3 763 
~-4 9:OO a.m.-l&30 a.m. 
B info@ACC Theater.. . 
DICOM, Booth 3 7 63 
B 9:OO a.m.-lOi30 a.m. 
m info@ACC Classroom 
. . .Microsoft PowerPoint 2000: 
Advanced, 
Booth 3 7 63, Classroom 7 a# 
m 9:OO a.m.-l&30 a.m. 
m info@ACC Classroom 
. ..Microsoft Office 2000, 
Booth 3 7 63, Classroom 2 
w lOi30a.m.~1i:lO a.m. 
m How to Desiqn Clinical 
Trials, Room 224C - m 
w lo:30 a.m.-1230 p.m. 
m ACC 2001 Meeting 
Highlights, Ha// E 
lo:30 a.m.-Noon 
m Controversies in 
Cardiology: Findings From Health 
Services Research, Room 304E 
w IO:30 a.m.-Noon 
m info@ACC Classroom 
. ..GB Stat, 
Booth 3 7 63, Classroom 7 m 
w l&30 a.m.-Noon 
m info@ACC Classroom 
. ..Adobe Photoshop: Basics, 
Booth 3 7 63, Classroom 2 m 
w 12:lS p.m.&45 p.m. 
m Compliance Issues in 
CPT Coding: Documentation = 
The Key, Room 705 
w 139.5 p.m.-W5 p.m. 
m The Cardiac Evaluation 
of Athletes, Room 702 
m Zkl!i p.m.-k45 p.m. 
m Heart Disease During 
Pregnancy, Room 703 
w 12:15 p.m.-&45 p.m. 
m It’s a Small World After 
All: Convergence of Professional 
Society Databases From Europe 
and North America, Room 706 
xxv 
e&de of Education Sessions 
arch 18,2001 
m State-of-the-Art Lectures: Treatment of I ,  . . lschemic Coronary Artery Disease, 
m (7:3O a.m.-8:45 a.m.), Ha//E 
m Optimizing Perfusion imaging in Everyday .I m Practice, (7:30 a.m.-9:OO a.m.), 
- Room 330 
Echocardiography in Valvular Heart 
p Disease, (8:OO a.m.-Noon), 
V”fO”n’” a 
m Echocardiography in lschemic Heart 
it: va/encid 0 
m Disease (8:00 am-l 0:15 am.), 
m Arrhythmia/Device Trial Update, 
(8:00 a.m.-l 0:OO a.m.), 
- &//A3 
v The Office and Hospital Practice of Nuclear 
=g!j=.’ _:’ Cardrology I Rermbursement and Creden- tralrng, (8.00 a.m.-9.00 a.m.), Room 340A 
Read With the Experts Focus on 
Technical Artifacts: Preventing, identifying, 
and Modifying, (8:00 a.m.-9:OO am.), 
Room340b: 
v Late Breaking Clinical Trials in II 
m Interventional Cardiology, 
L (845 a.m.-l 0:OO a.m.), Hall E 
v Advances in Technology and Applications: 
The Next Few Years, 
m (9:00 a.m.-10:OO a.m.), Room 330 
The Office and Hospital Practice of 
Nuclear Cardiology II: Improving 
Laboratory Efficiency, Effectiveness, and 
Potential, (9:00 a.m.-IO:00 a.m.), Room 340A 
m Read With the Experts...Focus on 
w Technique, Pitfalls, and Interpretation of 
Gated Single Photon Emission Computed 
Tomography, (9:00 a.m.-10:OO am.), Room 3408 
E/SE 
Basic Mechanisms in Heart Failure: Why 
- Does the Heart Fail?, (9:00 a.m.-Noon), 
Hall F4 
w New Guidelines for Management of 
L.,, Unstable Angina and Non ST-Elevation 
Myocardial Infarction, (9:00 a.m.-Noon), 
Room 304E 
Role of and Advances in Catheter 
Interventions, (9:00 a.m.-Noon), 
m Controlling Remodeling After Completed 
- Infarctions, (9:00 a.m.-Noon), 
Room4J4C 
Live Interventional Case Demonstrations I, 
m (l’lO;Op a.m.-Noon) 
Scientific Sessions 
m Physiologic and Anatomic Assessment: 3, 
m Case Reviews, (1O:OO a.m.-Noon), 
- Ho//F1 
m Arterial Access Issues, I I  .I (lo:00 a.m.-Noon), 
- Ho/IFS 
v Pacing/lmplantable Cardioverter 
.a Defibrillators in Heart Failure, 
m (1O:OO a.m.-Noon), Ha// A3 
m Diastology, 
.I m (lo:15 a.m.-Noon), 
- Valencia D 
m 
Applicatrons rn Coronary Artery Disease in 
;ys$tic~~lO:‘30 a.m.-Noon), 
gggg Comparing Programs for Quantitation of Perfusion and Function: A (Possibly) 
m Friendly Debate, (IO:30 a.m.-Noon), 
Room 340A 
m Read With the Experts Reading Lots 
m and Lots of Everyday Cases Along With 
the Experts, (lo:30 a.m.-Noon), 
Room3406 
All rooms are in the Orange County 
Convention Center unless otherwise noted. 
Orange CountyConvention Center, Ha//C 
Orange County Convention Center, Ha//sA4-DZ 
Poster Sessions 
gfjgy 18th Annual Symposium for Directors of 
Pedratnc Cardiology Programs (Luncheon), 
- (Noon-2:00 p.m.), Room JO6 
27th Annual Symposium for Directors of 
Adult Cardiology Training Programs, 
(Luncheon) (Noon.-1:30 p.m.), Room 300 
Moderated Poster Session...Advances in 
the Interventional Management of Acute 
Myocardial infarction, Ha// A4 
Advances in Noninvasive Imaging for 
ital Heart Disease, 
erm Statin Therapy: Regression, 
ty, and Low Density Lipoprotein, 
xxvi 
Dailv Schedule of Education Sessions 
J 
Sunday, March 18,200l 
Poster Sessions 
Intracardiac and Intravascular Ultrasound, 
New Methods for Detecting Vulnerable 
o Treat Heart Failure, 
w Therapeutic Approaches to Limit Post 
dial Infarction Remodeling, 
info@ACC Theater...Handheld 
Computing, (12:30 p.m.-l :30 p.m.), 
v info@ACC Classroom...Microsoft ,. 
. 1 PowerPoint 2000: Basics, 
v (12:30 p.m.-2:OO p.m.), 
Booth 3 7 63, Classroom 7 
w info@ACC Classroom... Windows ,. m 
m 2000: Basics, (12:30 p.m.-2:OO p.m.), 
Booth 3 7 63, Classroom 2 
Scientific Sessions 
Live and Taped Interventional 
Complications: Prevention, Recognition, 
and Management, 
(1:30 p.m.-3:15 p.m.), Ha// F7 
Problem Solving in Interventional 
(I:30 p.m.-3:lS p.m.), 
m Interventional Cardiology Highlighted II 
.* m Abstract Session...Coronary Stems: 
m Featured Investigation, 
(1:30 p.m.-3:15 p.m.), Hall F3 
m lntraoperative Echocardiography, 
m (1:30 p.m.-3:45 p.m.), 
Volencia A 
New Technologies, 
(1:30 p.m.-S:30 p.m.), 
Valencio D 
m 
m 
Interesting Case Studies, 
(1:30 p.m.-S:30 p.m.), 
Valencia B 
m New Mapping Techniques/Systems: When ,.. 
.a 
m Are They Needed?, 
p (1:30 p.m.-3:OO p.m.), Hall A3 
m Optimizing Decision Making in Acute 
h Coronary Syndromes, 
(1.30 p.m.-2:30 p.m.), Room 330 
Nuances of Optimizing Perfusion and 
m Function Imaging Protocols, 
(1.30 p.m. 2:30 p.m.), Room 340A 
Read With the Experts...Understanding 
and Applying Filtering and Attenuation 
Correction, (1:30 p.m.-2:30 p.m.), 
Room 340B 
Cardrovascular Disease Prevention 
m Insulin Resistant Patient 
in the 
m (2:00 p.m.-5:OO p.m.),‘Ho/l F4 
- Inflammation in Atherosclerosis, 
m Advances in Congenital Heart Disease ., 
m Imaging, (2:00 p.m.-S:00 p.m.), 
Room 4 7 4A 
m Determining Prognosis After Myocardial 
m Infarction, (2:00 p.m.-S:00 p.m.), 
m Room474C 
m info@ACC Theater...Wireless a. 
m Communications, 
m (2:00 p.m.-3:30 p.m.), Booth 3763 
m info@ACC Classroom...Windows ,. m 
mlifm 
2000: Basics, (2~00 p.m.-3:30 p.m.), 
Booth 3 163, Classroom 7 
info@ACC Classroom...Adobe aa 
Photoshop: Basics, (2:00 p.m.-3:30 p.m.), 
Booth 3 7 63, Classroom 2 
m a. Acute Coronary Syndromes, 
Scientific Sessions 
m Advances in Managing Coronary Artery 
m (2:30 p.m.-3:30 p.m.), Room 330 
Drsease/Left Ventricular Dysfunction, 
m Assessing and Quantifying Left Ventricular 
m Function and Volumes: Which Test When?, .I 
m (2:30 p.m.-3:30 p.m.), Room 340A 
m Read With the Experts...Difficult and 
m (2:30 p.m.-3:30 p.m.), Room 3408 
Challengmg Cases From Everyday Practice, 
..,.~,a,:.4 Hybrid Therapy for Atrial Fibrillation 
.I in 2001, (3:00 p.m.-?00 p.m.), 
m Ha//A3 
Great Debates in Peripheral Vascular 
m Ho,, F7 
Drsease, (3:30 p.m.-%30 p.m.), 
m Matching Lesions and Devices, II 
Heart Failure, 
(3:30 p.m.-l:30 p.m.), 
Auditorium 
m ,. info@ACC Theater...Voice 
I Recognition, (3:30 p.m.A:30 p.m.) 
- Booth3763 
m ,. info@ACC Classroom...Quicken aa 
a 2000, (3:30 p.m.-5:OO p.m.), 
Booth 3 7 63, Classroom 7 
m * info@ACC Classroom... *aa 
m 
m 
Web Site Basics: How to Build Your 
Own Web Site Using FrontPage 2000, 
(3:30 p.m.-5:OO p.m.), Booth 3763, Classroom 2 
Transesophageal Echocardiography, 
Interventional Cardiology Highlighted 
Abstract Session .Predictors of Restenosis, 
(4:00 p m.-5.3dp.m ) Hall F3 . . .,
Stump the Stars: Unknown Challenges 
Presented to Experts and Attendees, 
(4:00 p.m.-5:30 p.m.), Room 330 
All rooms are in the Orange County 
xxvii 
ailv Schedule of Education Sessions 
J 
Sunday, March 18,200l 
Poster Sessions 
Moderated Poster Session...Advanced 
Computer Applications in Cardiology: 
Neural Networks and Virtual Reality, 
Stabile lschemic Syndrome: Risk Factors 
k Factor Modification II, 
ation and Inflammation in Acute 
dial Infarction: Basic Observations, 
aluation of Coronary Disease by Exercise 
Pharmacological and Nonphanacologica 
enls for Congestive Heart Failure, 
Echo Assessment of Regional and Global 
1 
i- 
-l 
c 
Poster Sessions 
Contrast Echocardiography in 
cardial Infarction I, 
Genetic Polymorphisms in Coronary Artery 
Atherosclerosis and Thrombosis I, 
Evening Sessions 
1161.1*1 Advances in Contrast Echocardiography, 
m Valencio D 
Late Fontan Patients and Their Problems, 
Room 330 
Radiation Devices, 
Hall F3 
In-Stent Restenosis, 
Hall Fl 
Evaluation and Management of 
Neurocardiogenic Syncope, 
vchacia 6 
Alternative Revascularization Strategies, 
Hall F4 
Optimizing the Outpatient Management 
of Congestive Heart Failure in a Managed 
Care Environment, Room 304A 
m Noninvasive Evaluation of Heart Disease 
b in Women 
w Valencia A’ 
New pirections in Catheter-Based 
‘H”,;y 
Global Risk Approach for the Cardiologist, 
Room 2308 
All rooms are in the Orange County 
Convention Center unless otherwise noted. 
Orange County Convention Center, Halls A4-D2 
. . . 
XXVIII 
Daily Schedule of Education Sessions 
Monday, March 19,2001 
: II . l I I  .  
Scientific Sessions 
7 
Poster Sessions 
Moderated Poster 
Session...Progress in the 
Management of Congenital 
Heart Disease, Hall A4 
Meet the Experts 
It Congenital Heart 
ase: Electrophysiologic 
Anatomical Structural 
m 
Functional Assessment m 
of the Intermediate 
Coronary Lesions, Room 224A 
m Stent Selection, II m 
Room 2246 
Hall A4 
sistance and Inflammation 
m Are We Performing m 
m Too Many Coronary 
m Interventions?, Room 224C 
I:I Renal Percutaneous m 
,. Transluminal Angioplasty m and Stems. Room 224D 
m When and How to w 
m 
Use Beta-Blockers in Heart 
Failure. Room 224E 
New Methods for Detecting 
m Clinical Applications m of Positron Emmision Tomography, Room 2246 
Cardiac Magnetic m 
Resonance Imaging: 
Dobutamine Stress Testinq, 
Room 224H 
ral Arterial Disease II, 
info@ACC 
m info@ACC Computer ,. I 
- 
Applications...Electronic 
Record and Clinical Trials, 
(9:00 a.m.-12:30 p.m.), Booth 3763 
m info@ACC Theater... ,. 
0 
,’ Computerized Medical rm Solutions: How to Use 
Computerized Tools to Improve Patient 
Outcomes, Booth 3 7 63 
info@ACC Classroom m 
r 
. . info@ACC Classroom m 
a . ..The Internet Today, 
Booth 3 7 63, Classroom 2 
t. 
,* 
ascular Risk Factors, 
agnostic Indicators in 
tive Heart Failure, 
Poster Sessions (cont.) 
Coronary Artery Disease in 
the Elderly: Clinical Aspects, 
Hall A4 
Cardiomyopathy: 
Specific Types, 
Ho// A4 
Implantable Devices for the 
Treatment of Atrial 
Fibrillation. Ho// A4 
Atrial Fibrillation: Identi- 
fication and Elimination of 
Trinnwc Hnll A4 ...J =-.-, ..-.. 
Electrophysiological 
Properties of the Heart, 
Hall A4 
Coronary Artery Doppler, 
Cardiovascular Magnetic 
Resonance: Imaging the Lef 
Ventricle. Hall A4 
Optimizing Assessment of 
Ventricular Function: 
Advances in Radionuclide 
Techniques, Hall A4 
Ventricular Infarction, 
Stress Echocardiography: 
Hnfl A4 
Etiology of Aortic Valve 
Stenosis, 
All rooms are in the Orange 
County Convention Center 
unless otherwise noted. 
7:00 a.m.-5:OO p.m. 
Orange County Convention 
, 
Exhibit Hall Hours: 
9:00 a.m.-5:OO p.m. 
Orange County Convention 
Center, Halls A4-D2 
Scientific Sessions 
m Business Meeting of the ,. 
College, (9:15 am-930 a.m.) 
- Room 230B 
m Late Breaking Clinical , 
- p$FL 
n 
m ,. Improving the Quality of 
& Cardiovascular Care: 
Strategies for Preventing 
Medical Errors, Room 474C 
m Controversies in Cardiology I, . 
& (9:30 a.m.-10:30 a.m.) 
Room 2308 
v New Pharmacological 
Therapies for Heart Failure, 
- Room 330 - 
m I I  ACC/AHA Percutaneous 
2001, Hall F7 
m Valvular Heart Disease: Fran 
Bench to Bedside, 
- Valencia D 
Endothelium in Vascular 
Featured Oral Abstract 
Session...lnsights Into 
Myocardial Remodeling, 
Vdencio A 
Restenosis: 
Novel Therapies, 
Half F3 
Intravascular Ultrasound 
Guided Percutaneous 
Coronary Intervention I, 
Hall F4 
ercise Tolerance in 
Atrial Defibrillators, 
Echocardiographic 
Assessment of Atrial 
Fibrillation and Source of 
Embolus, Vdencia 6 
Unstable Plaque and Plaque 
xxix 
aily Schedule of Education Sessions 
Monday, March 19,200l 
Meet the Experts 
m Rotational II a# 
- 9. 
Atherectomy, 
Rnnm 7744 
Scientific Sessions 
m ABIM Town Meeting: A ,. 
m Discussion of Certification 
and Beyond, Auditorium 
- Young Investigators Awards 
- Competition: Physiology, 
Pharmacology, and 
Pathology, Room 4 74C 
,,,,q Atrial Fibrillation: .a 
- Room 330 
.a. From Cell to Bedside, 
v Current Status of Mitral 
- Hall Fl 
Valvuloplasty, 
lntracoronary Radiation: 
Advances in the Genetics of 
Congenital Heart Disease, 
m Advances in the Evaluation .I of Regional Myocardial 
- Function, Valencia D 
Interventional Case 
iiii!ii Ha,, E 
Presentations, 
m Optimizing Care in Acute I Myocardial Infarction, 
- Ha//A3 
m . 8, Inflammation and 
Endothelial Activation: 
Effects on Percutaneous 
Coronary Intervention Outcomes, Ha// f3 
m Brachytherapy: I> a- - Ongoing Issues, 
- Hall F4 
Acute Coronary Syndromes: 
m 
: I Cardiac Markers in Risk 
Assessment and 
Management Decisions, Room 2308 
w Stabile lschemic Syndrome: 
- Clinical Aspects, 
- Valencia A 
m Mechanisms Causing 
&& Myocardial Remodeling: 
Role of the Extracellular 
Matrix and Alterations in Matrix 
Metalloproteinases, Room 231A 
Room 304E 
Poster Sessions 
Moderated Poster 
Adult Congenital Heart 
Disease: Followup and 
Newer Interventional 
Computers in Cardiology II: 
Imaging and Diagnosis, 
Poster Sessions (cont.) 
m Preventive Treatment m I I  
qfter Intervention, 
- Room 2245 
n Are Anqiotensin EDELpl 
Recept% Blockers Better 
Than ACE-Inhibitors in Post- 
Atrial Fibrillation: Natural 
History, 
kInI/ A4 Infarct Remodeling?, Room 224C 
Evaluating and Treating m 
Pulmonary Hypertension, 
Room 2240 
Cardiovascular Issues m 
in Manned Space Flight, 
Room 224E 
HoN A4 
New Concepts About 
Atrioventricular Conduction; 
Left Atrial Size; Ouabain, 
Stabile lschemic Syndrome: * New Mechanical Therapies, 
- Ha//A4 
Atrial Fibrillation/Flutter: 
Thromboembolism, 
&h/l A4 
Evaluation and EIiE 
Management of Syncope, 
Room 224F 
Measurement of Infarct Size 
and Myocardial Protection, 
Ha// A4 
Resynchronization Therapy 
for Congestive Heart Failure 
II, Ha// A4 
m Cardiac Magnetic m 
b Resonance Imaging: Viability 
AwPwmmt Ronm 274c; 
Surgical Strategies for 
Pate;: With Heart Failure, SJ;;i;;Pate Imaging, 
General Clinical Risk Marker! 
in Acute Coronary 
Syndromes, Ha// A4 
Myocardial Perfusion During 
Acute Myocardial Infarction, 
Ha// A4 
Renal Interventions, 
m Hal/A4 
Echo Doppler Assessment of 
Vascular Disease, 
Hnll A4 
F 
Coronary Stents: Adjunctive 
;;;;ent, 
info@ACC Classroom m 
. ..Adobe Photoshop: Basics, 
Booth 3 7 63. Classroom 1 
Pharmacologic and Contrast 
Stress Echo, 
Hd A4 New Techniques: Strategies .* 
- 
for Intervention I, 
Ho// A4 i# New lnsiohts Into the m info@ACC Classroom m I .  
m Microsoft Office 2000, 
m k&h 3 163, Classroom 2 Restenosis: Vascular 
Remodeling and Apoptosis, 
- Ha//A4 
Angiogenesis and 
Nonvascular Precursor Cells, 
Cl”,, Ad 
info@ACC Theater... 
- 
DICOM (1l:OO a.m.-Noon), 
Booth 3163 
Hypertensive Heart Disease: 
., 
- 
Ventricular Function, 
Hall A4 
Small Dense LDL and 
Lipoprotein (a), 
Ha// A4 
Vascular Biology: Fish Oil, 
Hormones, Cytokines, and 
Endothelial Function and 
Registration Hours: 
7:00 a.m.-5:OO p.m. 
Orange County Convention 
Center, Ha// C 
Exhibit Hall Hours: 
9:00 a.m.-S:00 p.m. 
Orange Counly Convention 
Center, Halls A4-DZ 
All rooms are in the Orange 
County Convention Center 
unless otherwise noted. 
Inflammation and 
Atherosclerosis I, 
Hall A4 
Registration Hours: 
7:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Ha// C 
Exhibit Hall Hours: 
9:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Halls A4-D2 
Myocardial Remodeling, 
&&.& Ha/IA4 
Cardiac Allograft Rejection, 
6 Ha//A4 
Cardiomyopathy: Predictins 
Prognosis, 
Ha/l A4 
I  ,  
xxx 
Daily Schedule of Education Sessions 
Monday, March 19,200l 
Brown Bag Lunchtime Panels 
What Are the Options for 
Patients With End-Stage 
Heart Failure?, Room 10 I 
Diabetes and the 
Cardiologist: A Call to 
Action, Room 7 02 
Pediatric T&medicine, 
m Room 103 
Hypertrophic and Restrictive 
Cardiomyopathy: Diagnosis 
and Manaoement. Room 104 
;;;; $ocardiography, 
Women in Cardiology 
Committee Special 
Lunchtime Session: 
Professional Skills Development- 
;l:$a;;n and Conflict Resolution, 
- Cardiovascular Clinical 
m Pharmacology in the Elderly, 
Room 107 
K Management of Venous 
8: Thromboembolism, 
Room 108 
Case Studies of Mitral 
Regurgitation, 
Room 1096 
Case Studies of Aortic 
Stenosis, 
Room 7 1 iJB 
CP Ilb-llla Inhibitors: When 
Should They Be Used?, 
Room 1lOA 
info@ACC 
info@ACC Theater 
. ..Medline/Pub Med, 
(12:30 p.m.-l:30 p.m.), 
Booth 3 163 
info@ACC Classroom m 
. ..Microsoft Access 2000, 
Booth 3 7 63. Classroom I 
v info@ACC Classroom m ,. 
b . ..Microsoft PowerPoint 
2000: Basics, Booth 3 763, 
Classroom 2 
info@ACC Computer 
Applications...Database 
Applications in Cardiology, 
(1~10 n.m.-530 o.m.1. Booth 3163 
Scientific Sessions 
m Controversies in Cardiology ,. 
p II, (2:00 p.m.-S:30 p.m.), 
Auditorium 
m Young Investigators Awards I  
m Competition: Molecular and 
Cellular Cardiology, 
7oom 474C 
z ;;;pronary Devices, 
New Directions in Surgical 
Management of Valve 
Disease, Ha// F3 
m Prognostic Assessment After 
bb 
Myocardial Infarction, 
- Hormone Replacement 
.I Therapy and Cardiovascular 
m Disease, Ho// A3 
m Decision Making During 
.I Percutaneous Coronary . 
141: Intervention, Ho// E 
m Joint Symposium: European 
, m Society of Cardiology/ 
m American Colleae of 
Cardiology-Management Gf Acute 
Myocardial Infarction, (2:OO p.m.- 
530 o.m.1. Valencia A 
m Catheter Ablation of Atrial 
I., 
m :I 
Fibrillation, 
Room 232A 
v Featured Oral Abstract . . 
m Session...Outcomes 
Research: Key Studies From 
Large Databases in Coronary Artery 
Disease. Room 304E 
m Coronary Stents: Predictors 
* 
- 
of Outcome, 
Ho// F5 
li Carotid Interventions I, 
F Hall F4 *.. 
Novel Approaches to the 
Treatment of Heart Failure, 
New Management 
Cardiomyopathy: The 
Genetic Puzzle Unfolds I, 
y Myocardial Contrast 
- Echocardiography: New 
Developments, Valencia B 
v Interventional ., 
- , Catheterization: Strategies 
for Conqenital Heart 
Disease, Room 474A- 
Hormonal Modulation for 
Meet the Experts 
m Carotid Percutaneous m 
m Transluminal Coronary 
Angioplasty and Stenting: 
Indications and Technique-Case 
Reviews, Room 224A 
v Bifurcation Lesions, II m 
L.. 
Room 2248 
m Management of Right m 
- Ventricular Infarction- 
and Shock During Acute 
Myocardial Infarction, Room 224C 
- Running a m 
- Noninvasive Laboratory, 
Room 224D 
v How to Treat the Em 
& ,. Acutely Decompensated Heart 
Failure Patient, Room 224E 
m Prolonged QT m 
p Syndrome: From Cell to 
Bedsrde, Room 224F 
m Echocardiographic m 
m Approach to Selection of 
Patients for Mitral Valve 
Repair, Room 224G 
m Evaluation and m 
F Management of Prosthetic 
Valve Dysfunction, 
Room 224H 
info@ACC 
v info@ACC Theater ,. 
m . ..Digital Imaging 
Technology, 
(2:00 p.m.-3:OO p.m.), Booth 3163 
m info@ACC Classroom m ,. 
m . ..Microsoft 
PowerPoint 2000: 
Advanced, Booth 3 163, Classroom 1 
. . 
z 
info@ACC Classroom m 
. . ..&ickBooks Pro 
Booth 3 7 63 Clasiroom 2 
Poster Sessions 
v Moderated Poster r 
.I ‘1 Session...New Doppler 
m Techniques I, Ho// A4 
*.,+c~ Myocarditis: Systemic and 
I li Pulmonary Hypertension in 
m Children and Adults, Ha// A4 
m Population Based Studies of ,. 
. m Coronary Heart Disease, 
- Ha//A4 
Aortic Valve Stenosis, 
p Ha/f A4 .,. 
w Treatment Strategies for 
m Cardiac lschemic 
m Syndromes, Ho// A4 
wm Regulation of Angiogenesis 
q and Coronary Flow in Myo- 
m cardial Infarction, Ha// A4 
m Stabile lschemic Syndrome: 
.I Medical Therapies, 
- Ha//A4 
F Time to Treatment in Acute 
- Myocardial Infarction, 
- Ha// A4 
m Specific Clinical Risk Markers 
, in Acute Coronary 
m Syndromes, Ha// A4 
m II Coronary Stents: Clinical 
m Intravascular Ultrasound ,I 
I;ta Insights Into Atherosclerosis 
and Restenosis I, Hall A4 
m Local Delivery Approaches $8 
., _ i for Angiogenesis and 
m Restenosis, Ha// A4 
m New Techniques: Strategies /I 
. for Intervention II, 
- Ho// A4 
- Determination of Aortic 
.I Function and Distensibility, 
- Ho//A4 
Inflammation and 
.I 4 Atherosclerosis II, 
- Ha//A4 
F Reeaching Cholesterol Goals 
-a With Dietitians and/or the 
m Internet, Ha// A4 
_ Effect of Treatment on 
m .I Endothelial Function, 
- Ha// A4 
- Endothelial Function and 
m Nitric Oxide, 
- Ha//A4 
- Hypertension: Blood 
Pressure Control, 
- Ha//A4 
m Arrhythmias and Stroke in 
.,_ the Elderly, 
- Ha//A4 
m Mechanical Circulatory 
- SUPPOR 
- Ho//A4 
m Cardiomyopathy: Various 
.a Aspects, 
- Ho//A4 
xxxi 
ule of Education Sessions 
rch 19,200l 
info@ACC 
Meet the Experts 
m Interventions: Adult , 
L 1 Congenital Heart Disease, 
Room 224A 
m Management of Lipids 
Following Intervention, 
- Room 224B 
m Indications for and . . 
m Use,of,lmpla~table 
Deflbrillators in Pedlatrlc 
Patients, Room 224C 
m Pharmacotherapy of 
a.. 
Peripheral Arterial Disease, 
. Room 224D 
m The Art of Managing 
the Post-Transplant Patient, 
- Room 224E 
m Transcatheter Patent 
d&m 
Ductus Arteriosus Closure 
Methods, Room 224G 
m 
Miniaturization in 
Echocardiography: Are 
These Studies Diagnostic?, 
Room 224H 
Registration Hours: 
7:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Ha// C 
Exhibit Hall Hours: 
9:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Ha//s A4-LIZ 
Scientific Sessions 
m Young Investigators Awards ,. 
D Competition: Clinical 
- Investigations, Room 4 14C 
m Peripheral Artery Disease, , 
Ha// F5 
,--rl Overview of Genetic 
Arrhythmic Syndromes, 
- Hall F3 
T New T,herapies for Heart - 
Failure. Nonpharmacologlcal 
- Approaches, Vdencia D 
m Controversies in II 
L., 
;$,ytional Cardiology, 
m Genetics of Cardiovascular 
.I 
b: 
Disorders, 
Room 3?0 
Renal Artery Stenosis: 
Diagnosis and 
Management, Ha// FJ 
- Genetics and Vascular 
8 Disease, 
- Hal/A3 
Natriuretic Peptide Measure- 
ments for Diagnosing and 
Managing Heart Failure, 
Combination Strategies for 
Managing Acute Myocardial 
Infarction. Room 230D 
New Concepts About 
Atrial Fibrillation, 
Room 232A 
I Total Cholesterol 
Hypertensive Heart Disease: 
Flow and Function, 
ACC Chapter Night 
Members of the following ACC 
Chapters are invited to attend 
their ACC 2001 receptions. 
I\labama, Louisiana, Tennessee, 
Kentucky & Mississippi- 
Rosen Plaza, Salon 7 
California-Rosen Centre, Signature 1 
Florida-Rosen Plaza, Salon 5 
Illinois-Rosen P/aza, Salon 4 
Indiana-Rosen Centre, Solon 2 
Iowa-Rosen Plaza, Salon 7 3 
Kansas-Rosen Centre, Salon 12 
Maryland-Rosen Plaza, Salon 70 
Massachusetts-Rosen Plaza, Salon 9 
Michigan-Rosen Centre, Signature 2 
Minnesota-Rosen Plaza, Salon 6 
Missouri-Rosen Center, Salon 1 I 
New Jersey-Rosen Plaza, Salon 8 
New York-Rosen Centre, Salon 9 
North Carolina & South Carolina- 
Rosen Centre, Salon I 
Northern New England Tri-State- 
Rosen Plaza, Salon 74 
Oklahoma-Rosen P/aza, Salon 78 
Oregon-Rosen P/aza, Salon 2 
Pennsylvania 8 Ohio- 
Rosen Centre, Salon IO 
Rhode Island-Rosen Centre, Salon 4 
Texas-Rosen Plaza, Salon 7 
Virginia-Rosen Plaza, Salon 3 
Washington State- 
Rosen Centre, Salon 5 
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Daily Schedule of Education Sessions 
Tuesday, March 20,200l 
Scientific Sessions 
m Late Breaking Clinical Trials II, a. 
Ho// E 
m Controversies in Cardiology ,. 
III, (8:30 a.m.-Noon), 
m Auditorium 
m Magnetic Resonance 
.* 
. Imaging in lschemic Heart 
- Disease, Valencia A 
m New Insights in Plaque 
Vulnerability: Novel Imaging 
m Techniques, Volencia D 
- Sipping Tea for the Heart, 
- Ha//A3 , 
m Antiarrhythmic Drugs: What 
.I Every Cardiologist Needs to 
- Know, Room 330 
m ,, Controversial Issues in 
m How to Prevent Heart 
Failure?, 
- Hall F3 
m Acute lschemic Syndromes, ,, 
a. Hall F7 
Featured Oral Abstract 
Session...Advances in 
Surgery for Congenital 
Heart Disease, Room 4 74A 
Therapeutic Angiongenesis 
Syndromes, Room 2300 
Atrial Fibrillation: Natural 
History, Thromboembolism, 
and Pathophysiology, 
Room 232A 
Vascular Function, Vdencia L 
Meet the Experts 
m Approaching the I I  
CEF 
Lesions With Thrombus, 
Ronm 7744 
,..., Case Studies in Valvular 
\ Disease: Aortic Stenosis and 
Low Output, Room 2248 
- Pre-Operative Cardiac 
&& Eva.3;;~; 
m How to Use Doppler ., 
?- 
1 Techniques to Evaluate 
Diastolic Function, 
Room 224F 
m Post Myocardial 
b 
infarction Assessment: 
Aqqressive or Conservative?, 
Room 224G -- 
m Uses of and ., 
‘1 Indications for Coumadin in , 
Fontan Patients, Room 224H 
info@ACC 
m info@ACC Computer Appli- *. 
. 
L 
cations...Clinical Cardiology: 
Care at a Distance, 
(9:00 a.m.-12:30 p.m.), Booth 3163 
m info@ACC a. * 
rm Theater...lntemet- 
Emoowered Consumers: 
Their Effect on Healthcare, Booth 3 7 63 
m info@ACC Classroom 
d . ..Microsoft Access 2000, 
Booth 3 7 63, Classroom 7 
Using FrontPage 2000, Booth 3763, 
Classroom 7 
Poster Sessions 
Moderated Poster 
Session...Nonlipid Effects of 
Statin Theraov. Hull A4 
Cardiomyopathy and 
Congenital Heart Disease: 
Access, Followup, and 
Quality of Life, Ha77 A4 
Stabile lschemic Syndrome: 
Stress Testing and Risk 
Stratification. Half A4 
vel Risk Markers and 
eutic Interactions, 
Beyond Lipids: Inflammatory 
Hypertensive Heart Disease: 
iotensin II Blockade and 
‘otensin-Converting 
me Inhibition Hall A4 
Cellular and Molecular 
Poster Sessions (cont.) 
Biochemical and 
Neurohormonal Markers of 
Prognosis in Heart Failure, 
Ha//A4 - 
tions on Cardiac 
Echocardiography: 
Perfusion, Metabolism, and 
Hall A4 
Echo Assessment of Novel 
Detection of Myocardial 
Myocardial Contrast 
Echocardiography for 
Assessing Blood Flow 
Reserve, Hall A4 
Registration Hours: 
7:30 a.m.-5:OO p.m. 
Orange County Convention 
i Center, Hall C 
Exhibit Hall Hours: 
9:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Halls A4-D2 
. . . 
XXXlll 
Schedule of Education Sessions 
Tuesday, arch 20,2001 
Meet the Experts 
m Alcohol Ablation for *, 
e Hypertrophic Obstructive 
Cardiomyopathy, 
Room 224A 
m Renal Artery Stenting: #, 
q Techniques, Complications, 
- Avoidance. and Case 
Reviews, Room 2248 
m Management of ., 
m Infants With Tachycardia, 
Room 224 C 
w Should All Patients 
ba,, With an Abnormal Stress 
Imaging Study Undergo 
Coronary Arteriography?, Room 224D 
V Assessing and 
6 Managing Cardiac Risk of 
Noncardiac Surgery, 
Room 224E 
” ‘~q Ventricular Arrhythmias: 
h Who Needs Treatment?, 
Room 224F 
Attenuation Correction: 
Needed or Not?, 
Room 224G 
Management of 
Complex Left Ventricular 
Out Flow Tract Obstruction. 
Room 224H 
Registration Hours: 
7:30 a.m.-5:OO p.m. 
orange County Convention 
Exhibit Hall Hours: 
9:00 a.m.-S:00 p.m. 
Orange County Convention 
Center, Halls A4-D2 
Scientific Sessions 
Clinical Decision Making, 
Hall F3 
Alternatives and Comple- 
mentary Practices in Cardio- 
vascular Disease, Hall A3 
m Joint Symposium: American 
College of Physicians- 
- American Society of Internal 
Medicine/American College of 
Cardiology-Management of Chronic 
Stable Angina in Special Patient Groups, 
Room 330 
Na;~;djunctive Therapy, 
llnnrrmr Controversies in Pediatric , I  
Cardiology, 
- Valencia D 
Why My Diet Is the Best, 
T Noninvasive Assessment of 
- Myocardial Viability, 
- Vdencia A 
Featured Oral Abstract 
Session...Advances in 
Featured Oral Abstract 
Session...Thrombosis and 
Antithrombotic Agents, 
Room 304E 
Hall F4 
Radiation Therapy for 
Restenosis: Insights From 
Intravascular Ultrasound, 
Mechanisms Causing 
Myocardial Remodeling: 
Role of Cytokines and 
Apoptosis, Room 230B 
Secular Trends in the Man- 
agement of Acute Myocardia 
Infarction Room 7301) 
Cardiovascular Therapy in 
the Elderly: Safety, Efficacy, 
Outcomes, and Eligibility, 
Room 23 IA 
Resynchronization Therapy 
for Congestive Heart Failure I, 
Room 232A 
Peripheral Arterial Disease I, 
info@ACC 
m info@ACC Theater.. ,. 
b Wireless Communications, 
(11:00 a.m.-Noon), 
Booth 3 163 
m info@ACC Classroom . 
m . ..Windows 2000: 
Advanced, Booth 3 163, 
Classroom 7 
m 8. info@ACC Classroom 
Poster Sessions 
Moderated Poster Session 
r Intervention- 
and Electrophysiology, Hall A4 
Outcomes Research in Acute 
Myocardial Infarction and 
Coronary Heart Disease, 
and Marker Release in the 
lschemic Myocardium, 
Ho/l A4 
Complications of Acute 
Transmyocardial Laser 
Revascularization: Positive, 
Negative, or Neutral?, 
Risk Factors and 
Endothelial Dysfunction Ill, 
Failure II, Ha// A4 
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Daily Schedule of Education Sessions 
Tuesday, March ,20, 2001 
Poster Sessions (cont.) 
ailure in the Elderly: 
Pericardial Disease: 
Clinical Aspects, 
Hall A4 
Atrial Fibrillation: 
Catheter Ablation of Atrial 
uantitative Myocardial 
Computed Tomography/ 
Icification-Risk 
Stress Echocardiography: 
Coronary Flow Reserve and 
Ischemia. HoN A4 
Contrast Echocardiography 
Imaging Parameters, 
Hall A4 
.( 
Registration Hours: 
7:30 a.m.-S:00 p.m. 
Orange County Convention 
Center, Ha// C r----- Exhibit Hall Hours: 9:00 a.m.-S:00 p.m. Orange County Convention Center, Halls A4-D2 
Brown Bag Lunchtime Panels 
ml&h 
m Inoperable Coronary 
Artery Disease, 
- Room 109A 
m Low Molecular Weight 
d Heparin, 
- Room llOA 
m3zai.m 
- The Benefits of Aggressive 
Lipid-Lowering Therapy in 
- Coronary Artery Disease, 
Room 109B 
m Heart Failure in the Patient 
m35iami With Preserved Systolic 
- Function: How Should It Be 
Diagnosed and Treated?, Room 7 706 
m Common Errors in the 
ms&& - Management of Heart 
Failure, Room 7 08 
mrZmnm Evaluation of the Patient 
ms!im& With Idiopathic 
Cardiomyopathy: How Far 
to Co?, Room 705 
mxlkm 
m Echocardiography in Acute 
Myocardial Infarction, 
lFIT Room 101 
m Noninvasive Risk Stratifi- 
cation Post-Myocardial 
- Infarction, Room 702 
ii&m 
m Management of Post- 
Thoracotomy Atrial 
- Controversies in 
& Renovascular Disease, 
- Room 704 
& 
m Follow-Up Results in Young 
Adults Post-Operative 
- Arterial Switch. Room 7 07 
info@ACC 
m info@ACC Computer Appli- . 
8. cations...Computer Appli- 
IFn cations in Echocardiography, 
(1:30 p.m.-S:30 p.m.), Booth 3163 
v info@ACC Theater...Hands- *  * 
On Palm, (12:30 p.m.- 
IFn 1.70 n m.1 Rooth 3763 . __ r . . .  ... ---... --
m info@ACC Classroom 
I . ..Quicken 2000, 
IR1 Rooth 716X 
m info@ACC Classroom 
F . ..Microsoft PowerPoint 
m 2000: Advanced, 
Booth 3 163. Classroom 2 
info@ACC 
m info@ACC Theater... 0. 
r;)r Photoshop and Software 
Solutions, (2:OO p.m.- 
3:OO p.m.), Booth 3 I63 
m info@ACC Classroom ,  
I . ..Adobe Photoshop: Basics, 
lril Booth 3 J 63, Classroom 7 
Scientific Sessions 
m 32nd Annual Louis F. Bishop . . 
: Lecture, (2:00 p.m.- 
lcFr 3:00 p.m.), Room 330 
m Lessons From Angioplasty II 
Versus Surgery in Multivesse 
m Disease: Have Our 
Conclusions Changed With Extended 
Long-Term Follow-Up?, Hall E 
m Cardiac Remodeling: From 
.a Animal Models to Patients, 
1 Auditorium 
‘~ ..1 Nonpharmacologic 
Treatment of Atrial : 
m Fibrillation, Hall F3 
m What Constitutes a 
. . Diagnosis of Myocardial 
- Infarction in 2001?, Hall F4 
m Pathways for Monitoring .> 
.a 
. . I 
and Advancing Congenital 
- Heart Disease Care, 
Room 2300 
m Sesion Conjunta con la 
Sociedad Interamericana de 
. . 
m Cardiologia/Sociedad 
Espanola de CardiologiaiAmerican 
Colleae of Cardioloav-Problemas 
Relev&tes en Cardglogia: 2001, 
Valencia 73 
W Infection and 
. . 
. . Atherosclerosis, 
- Holl A7 
m Advances in Cardiovascular 8. 
a. 
8: Surgery: Valves, Stent 
m Grafts, and Robots, 
Valencia A 
Coronary Stents: Late 
Outcome, 
Ho// Fl 
Percutaneous Septal 
Ablation for Hypertrophic 
Obstructive Cardiomyopathy 
The Latest Data, Hall F5 
Catheter Ablation of 
Ventricular Tachycardia, 
Room 230B 
Evolving Parametrics of Risk 
and of Quality of Life After 
Acute Coronary Syndromes, . 
Valencia D 
Outcomes Research 
Percutaneous Coron 
Risk Stratification in Patients 
With Organic Heart Disease, 
Vascular Biology and 
Angiogenesis: Clinical 
Studies. Room 304A 
xxxv 
v Schedule of Education Sessions 
arch 20, 2001 
Meet the Experts 
Treatment of 
Saphenous Vein Graft 
Disease, Room 224A 
m My Worst Nightmares 0, 
m as an Interventionalist, 
- Room 2248 
Regurgitant Severity: A 
Practical Approach, 
!oom 224C 
m Managing the Elderly 
Hypertensive Patlent, 
- Room 2240 
m How to Set Up a 
m Digital Echocardiography 
m Lab, Room 224E 
Management of 
Unstable Angina, 
Room 224F 
m Stress Echocardio- 
lcfFmR graphy: What to Do and 
m What Not to Do, Room 2246 
B Strategies for ,. 
r Treating Post-Operative 
Patients With Decreased 
Cardiac Outout. Room 224H 
Poster Sessions 
Moderated Poster 
Outcomes Research in 
tive Heart Failure, 
mia: Focus on Nitric 
e and Coronary Flow, 
Percutaneous Coronary 
e Transfer, Inflammation 
ointima Formation, 
Endothelial Dysfunction IV, 
Mechanical and 
Neurohormonal Mechanism 
Effecting Myocardial 
Function, Ha// A4 
Poster Sessions (cont.) 
Experimental Transplant, 
Ha// A4 
asive Assessment of 
Arrhythmia Mechanisms, 
Hall A4 
Cardiac Pacing II, 
Ho/l A4 
Atrial Tachycardia and 
Inappropriate Sinus 
Tachycardia: Localization 
and Ablation. Ha// A4 
Atrial Fibrillation: 
;I;dF4version, 
New Doppler Techniques II, 
Ha/l A4 
Cardiovascular Magnetic 
Resonance: Flow Reserve, 
Viability, and Safety, Hall A4 
Assessing lschemia and 
Coronary Artery Disease: 
Implications for Decision 
Making and Outcomes, Hall A4 
Clinical and Experimental 
Echo Studies in Diastolic 
Dobutamine Stress Echo: 
Miscellaneous Applications, 
Myocardial Contrast 
Echocardiography: Real- 
Time Imaging, Ha// A4 
info@ACC 
m info@ACC Theater... 
4 DICOM, (3:30 p.m.- 
m 4:30 p.m.), Booth 3163 
m info@ACC Classroom 8. 
c ;‘, . ..Microsoft PowerPoint 
2000. Advanced, 
Booth 3 163, Classroom 1 
. . info@ACC Classroom 
. ..QuickBooks Pro 2000. 
I 
All rooms are in the Orange 
County Convention Center 
unless otherwise noted. 
Registration Hours: 
7:30 a.m.-5:OO pm. 
Orange County Convention 
Center, Ha// C 
Exhibit Hall Hours: 
9:00 a.m.-5:OO p.m. 
Orange County Convention 
Center, Halls A4-D2 
xxxvi 
Dailv Schedule of Education Sessions 
J 
Tuesday, March 20, 2001 
Scientific Sessions 
Special Report: Clinical 
Outcomes From the ACC- 
National Cardiovascular 
Data Registry, Room 2308 
m 32nd Annual Bethesda ,. 
Conference Report: Care of 
the Adult Survivor With 
Congenital Heart Disease, Room 414C 
m Controversies in ,. 
m Cardiology IV, 
m Carotid Intervention, ,, . Hall E 
m Prediction of Viability in 
m Auditorium 
Chronic Coronary Disease, 
m Impact and Limitations of 
, Heart Failure Clinical Trials, 
n Room 330 ., 
m Myocardial ,, .a Revascularizationi . . 
n Angiogenesis, Ho/l F7 
m Experimental Therapies of .a 
. . Acute Myocardial 
- Ho// F4 
Infarction, 
m Advances in Management 01 8 
n Room 230D ..: 
Pulmonary Hypertension, 
m Diet Drugs: Lessons 
.a 
n Hall A3 .I’ 
Learned, 
College of Cardiology-Findings and 
Recommendations of the Joint 
Committee on Ethnic and Gender 
Disparities in Access to Quality 
Cardiovascular Care, Room 304E 
m Changing indications for 8. v Surgical Intervention in IF’ 
q Patients With Valvular Heart 
Disease, \/a/en& A 
Outcome Markers During 
Percutaneous Coronary 
Interventions HUN F5 
Differences in Heart Failure, 
able Cardioverter 
Tomography/Magnetic 
Resonance Imaging: 
lschemic Heart Disease, Valencio B 
Meet the Experts 
m Excimer Laser 
w Angioplasty in 2001, 
m Room 2246 
.g:m What’s New With 
m 
Antiarrhythmic Drugs, 
Room 224C 
m Clinical Assessment of 
Success of Reperfusion: Is It 
Pocrible?. Room 224D 
m How and Why to 
Design an Exercise Program 
m for Your Heart Failure 
Patient. Room 224E 
v Difficult Hemodynamic 
Situations: Assessment and 
Manaoement. Room 224F 
m Contrast Echo- 
m 
m 
cardiography for Myocardial 
Perfusion: How to Get 
Started. Room 224G 
m ., Kawasaki Disease 
Management, 
- Rnom224H 
Evening Sessions 
I 
Scientific Sessions 
I 
1 Point-of-Care Platelet 
” 1 Aggregation Monitoring, 
1 Hoff FC 
m Cardiac Pathology in Heart 
Xlure: New Insights, 
Noninvasive Screening for 
! Atherosclerosis, 
Valencia 8 
m Advances in Nuclear 
Hypoxia, Room 4 7 4A 
Hall $4 
v Management of Atrial 
m Fibrillation in 2001, 
m Room 23 1 A 
Exhibit Hall Hours: 
9:00 a.m.-5:OO p.m. 
Orcmge County Convention 
Center, Halls A4-D2 
xxxvii 
edule of Education Sessions 
dnesda, March 21, 2001 
Scientific Sessions 
m Update on Cardiac . 
Transplantation, 
- Room 330 
v Restenosis: Prevention and 
., Treatment, 
- Hall FS 
m Defibrillation: 
Theory and Practice, 
- Ho// F3 
gg!g 
Multicenter Registries: What 
I’ve Learned From Our 
Registry That Has Changed 
Our Clinical Practice, Ho// fl 
m End-Stage Adult Congenital I 
. . Heart Disease Management, 
- Room 2300 
- The Transatlantic 
d Intersociety Consensus on 
the Management of 
Peripheral Arterial Disease, Ha// A3 
isk Factors in Minority 
Myocardial Infarction, 
Arrhythmias: Anatomy, 
Mapping, and Ablation, 
Room 232A 
Meet the Experts 
Chronic Total 
p Occlusions 
Room 224A 
m Role of Transeso- 
L’ Phageal Echocardiography 
in Valve Surgery, Room 2245 
m Importance of 
b 
Evaluating Left Ventricular 
Function in the Post- 
Myocardial Infarction Patient, 
Room 224C 
,+‘4 Evaluation of 
: Syncope in the Elderly, 
- Room 224F 
info@ACC 
m info@ACC Computer ,. . 
Applications...Computers in 
Icm Cardiology, (9:00 a.m.- 
Noon), Booth 3 I63 
m info@ACC Theater... 3. 
. DICOM, 
- Booth 3 7 63 
t. 
m 
info@ACC Classroom 
. . . . ..cro$t~$derPoint 
Booth 3 163. Classroom 1 
m info@ACC Classroom *. 8 
, . ..Microsoft Office 2000, 
- Booth 3 163, Classroom 2 
Poster Sessions 
Moderated Poster Session. 
Tracers and Techniques, 
Computed Tomography/ 
Magnetic Resonance 
Inhibition of Platelets and 
Thrombosis in Percutaneous 
Coronary Intervention: 
Progress in Agents and indications, 
Ho// A4 
Intravascular Ultrasound 
Guided Percutaneous 
Coronary Intervention II, 
Poster Sessions (cont.1 
Implantable Cardioverter 
!X;$rjlators Ill, 
Risk Factors for 
Atherosclerosis, 
ndl A4 
Coronary Artery Disease ant 
Various Pharmacologic 
Aoents. Ho// A4 
Novel Biochemical Markers 
of Atherosclerosis, 
Ho// A4 
Miscellaneous Topi 
Murine Heart cailure, Ha// A4 
-...diovascular Disease in 
the Elderlv: Miscellaneous 
All rooms are in the Orange 
County Convention Center 
unless otherwise noted. 
1 
I 1 
Registration Hours: 
8:00 a.m.-Noon 
Orange County Convention 
Center, Ha// C 
Exhibit Hall Hours: 
9:00 a.m.-Noon 
Orange County Convention 
Center, Halls A4-D2 
. . . 
XXXVlll 
Daily Schedule of Education Sessions 
Wednesday, March 21,200l 
Meet the Experts 
m Intervention ( I  
in Multivessel Disease, 
- Room224A 
m Acute Myocardial I I  
m How to Design *  
m Clinical Trials, 
Room 224C 
- Evaluating and 
&& Managing the Hypercoagu- 
lular State, Room 224E 
m Arrhythmias in 
Athletes, 
- Rnom 774F 
Novel Approaches, 
Acute Myocardial infarction 
Angioplasty: When, Where, 
Room 304A ’ 
Natural Historv of Valvular 
- 
Echocardiography in 
Coronary Artery Disease, - ._.^ 
Coarctation: Late Sequelae 
in the Young Adult, 
Room 101 
The Cardiac Evaluation 
of Athletes, 
Room 102 
Heart Disease During 
Pregnancy, 
Room 103 
Anaiotensin Receotor 
‘:‘i;“\q 8 I/ -+a .,, s,j,.” ‘.xs.,&:p :;ig,: & 
.i. a  & 5’ /,’ ”  ,I,” ”  ili -  / m It’s a Small World After All: 
Convergence of Professional 
Society Databases From 
Laboratory, Room 107 
Findinas From Health 
All rooms are in the Orange 
County Convention Center 
unless otherwise noted. 
Registration Hours: 
8:00 a.m.-Noon 
